_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,exp_decision,relation,sent_id,orig_sentence,term1,term2
788747770,9/15/2015 16:26:28,1738775714,9/15/2015 16:26:18,false,bitcoinget,1,21743413,USA,WA,Port Angeles,24.113.29.97,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,33,GLUCOSE,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:31:26,1738777354,9/15/2015 16:31:09,false,instagc,1,18960682,GBR,U2,Annan,92.18.213.181,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,27-33-41,blood GLUCOSE levels,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:37:14,1738779344,9/15/2015 16:37:00,false,elite,1,34356654,USA,DE,"",108.59.11.227,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,after intensive exercise prevent or abort HYPOGLYCEMIA.,58-74-86-94-97-103-64,16-21-27-33-41-48-55-58-64-74-103,also check blood GLUCOSE levels before or after intensive exercise hypoglycemia.,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:39:33,1738780389,9/15/2015 16:38:26,false,elite,1,30312592,CAN,ON,Sudbury,66.103.55.12,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,27-33-41,blood GLUCOSE levels,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:42:29,1738781952,9/15/2015 16:42:12,false,prodege,1,6309240,USA,CA,San Diego,108.178.173.218,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,27-33-41-55,blood GLUCOSE levels or,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:46:11,1738784715,9/15/2015 16:45:08,false,clixsense,1,33878524,CAN,BC,Princeton,75.156.83.71,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,27-33-41,blood GLUCOSE levels,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:47:19,1738785578,9/15/2015 16:47:07,false,neodev,1,30627835,GBR,D8,Bishop Auckland,217.44.84.223,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,27-33-41,blood GLUCOSE levels,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:54:52,1738791960,9/15/2015 16:54:42,false,elite,1,33798502,USA,VA,Manassas,207.244.77.3,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,blood glucose intensive prevent or abort HYPOGLYCEMIA.,33-64-86-94-97-103-27,16-21-27-33-41-48-55-86-103,also check blood GLUCOSE levels before or prevent hypoglycemia.,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 16:55:42,1738792676,9/15/2015 16:54:54,false,instagc,1,26024737,GBR,H2,Preston,78.144.133.234,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA.,103,33,GLUCOSE,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747770,9/15/2015 17:10:54,1738807735,9/15/2015 17:10:41,false,zoombucks,1,4711962,CAN,ON,Markham,174.88.29.138,103,33,,,115,40,HYPOGLYCEMIA,GLUCOSE,intensive exercise to prevent or abort HYPOGLYCEMIA.,64-74-86-94-97-103-83,16-21-27-33-41-48-55-58-64-74,also check blood GLUCOSE levels before or after intensive exercise,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia.,103,33,103,33,115,40,-1,RO-may_treat,820090,Patients should also check blood glucose levels before or after intensive exercise to prevent or abort hypoglycemia,hypoglycemia,glucose
788747771,9/15/2015 17:23:06,1738814675,9/15/2015 17:22:49,false,gifthunterclub,1,29582088,GBR,I2,Manchester,2.99.153.19,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:09:42,1738879609,9/15/2015 18:09:17,false,neodev,1,14861092,GBR,V2,Glasgow,90.214.139.127,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:19:34,1738888569,9/15/2015 18:19:17,false,neodev,1,20306047,GBR,"","",80.41.0.252,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:25:24,1738892257,9/15/2015 18:25:10,false,instagc,1,31184650,USA,IA,Mason City,173.26.179.94,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:26:03,1738892549,9/15/2015 18:25:50,false,gifthunterclub,1,31241093,GBR,Q1,Wallasey,2.217.117.151,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:26:43,1738892900,9/15/2015 18:26:31,false,instagc,1,20312760,GBR,O1,Dukinfield,2.96.59.31,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:27:43,1738893483,9/15/2015 18:27:26,false,clixsense,1,19638651,USA,SC,Summerville,174.107.73.211,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:35:56,1738898599,9/15/2015 18:35:36,false,neodev,1,33758777,USA,"","",38.95.108.251,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:36:55,1738899216,9/15/2015 18:35:32,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23-31,INSULIN response,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747771,9/15/2015 18:37:48,1738899780,9/15/2015 18:37:18,false,inboxpounds,1,12317706,GBR,J1,Wellingborough,86.164.164.220,106,23,,,119,30,HYPERGLYCEMIA,INSULIN,HYPERGLYCEMIA,106,23,INSULIN,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug.",106,23,106,23,119,30,-1,RO-may_treat,820111,"In contrast, the later insulin response was enhanced, probably mainly as a result of the higher degree of hyperglycemia induced in experiments with the drug",hyperglycemia,insulin
788747772,9/15/2015 16:02:49,1738766817,9/15/2015 16:00:18,false,elite,1,31883685,GBR,"","",79.66.244.188,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:02:58,1738766909,9/15/2015 16:02:36,false,prodege,1,22031444,GBR,F2,Gosport,92.24.223.243,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:04:52,1738767580,9/15/2015 16:04:40,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.123,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:07:34,1738768697,9/15/2015 16:07:08,false,clixsense,1,32053717,GBR,"","",51.174.76.80,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,"of cases of TUBERCULOSIS isoniazid rifampicin, pyrazinamide ethambutol",57-60-66-69-105-119-136-153,69-102-105-115-119-131-136-149-153,"tuberculosis of isoniazid and RIFAMPICIN, plus pyrazinamide and ethambutol","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:09:53,1738769596,9/15/2015 16:09:30,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.124.79,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:11:10,1738769990,9/15/2015 16:10:47,false,fusioncash,1,5861591,USA,OK,Muskogee,74.197.206.241,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:12:48,1738770504,9/15/2015 16:12:33,false,instagc,1,15577915,USA,IL,Trenton,208.70.36.12,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:12:46,1738770505,9/15/2015 16:12:09,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS 6 -,69-87-88,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:12:58,1738770549,9/15/2015 16:11:54,false,points4rewards,1,20113482,USA,PA,Philadelphia,162.208.49.45,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,69,119,"RIFAMPICIN,","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747772,9/15/2015 16:14:39,1738771299,9/15/2015 16:13:34,false,clixsense,1,33115750,GBR,I3,Rochester,90.222.106.192,69,119,,,81,129,TUBERCULOSIS,RIFAMPICIN,"TUBERCULOSIS 6 isoniazid rifampicin, pyrazinamide ethambutol",69-87-105-119-136-153,105-115-119-131-136-149-153,"isoniazid and RIFAMPICIN, plus pyrazinamide and ethambutol","The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months.",69,119,69,119,81,129,-1,RO-may_prevent,820198,"The recommended treatment protocol for the vast majority of cases of tuberculosis is a 6-month course of isoniazid and rifampicin, plus pyrazinamide and ethambutol for the first two months",tuberculosis,rifampicin
788747773,9/15/2015 16:24:21,1738774981,9/15/2015 16:24:06,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,TUBERCULOSIS,93,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:25:26,1738775332,9/15/2015 16:25:05,false,prodege,1,27934334,GBR,C8,Croydon,81.159.60.206,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"latent TUBERCULOSIS infection,",86-93-106,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:25:27,1738775348,9/15/2015 16:25:11,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"rifampin and pyrazinamide for latent TUBERCULOSIS infection,",56-65-69-82-86-93-106,56-65-69-82-86-93-106,"rifampin and PYRAZINAMIDE for latent tuberculosis infection,","Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:27:42,1738776177,9/15/2015 16:27:28,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"latent TUBERCULOSIS infection,",86-93-106,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:30:22,1738777049,9/15/2015 16:29:38,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,TUBERCULOSIS,93,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:35:07,1738778593,9/15/2015 16:34:55,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"pyrazinamide for latent TUBERCULOSIS infection, and revisions American Thoracic recommendations?United",69-82-86-93-106-117-121-134-143-164,51-56-65-69-82-86-93-134,with rifampin and PYRAZINAMIDE for latent tuberculosis American,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:35:13,1738778622,9/15/2015 16:35:03,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,TUBERCULOSIS,93,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:35:13,1738778633,9/15/2015 16:34:37,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"TUBERCULOSIS infection,",93-106,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:36:03,1738778889,9/15/2015 16:35:42,false,clixsense,1,22947672,GBR,H9,London,146.198.116.72,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"pyrazinamide for latent TUBERCULOSIS infection,",69-82-86-93-106,31-51-56-65-69-82-86-93-106-40,"injuries associated with rifampin and PYRAZINAMIDE for latent tuberculosis infection,","Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747773,9/15/2015 16:36:05,1738778909,9/15/2015 16:34:58,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,93,69,,,105,81,TUBERCULOSIS,PYRAZINAMIDE,"latent TUBERCULOSIS infection,",86-93-106,69,PYRAZINAMIDE,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001.",93,69,93,69,105,81,-1,RO-may_prevent,820268,"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations?United States, 2001",tuberculosis,pyrazinamide
788747774,9/15/2015 18:23:13,1738890901,9/15/2015 18:22:55,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,91,CALCITONIN,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:29:24,1738894441,9/15/2015 18:29:07,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,91,CALCITONIN,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:30:39,1738895203,9/15/2015 18:30:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,85-91-102,basal CALCITONIN levels,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:31:53,1738896061,9/15/2015 18:31:31,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,85-91-102,basal CALCITONIN levels,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:40:38,1738901445,9/15/2015 18:40:16,false,neodev,1.0,33758777,USA,"","",38.95.108.251,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,91,CALCITONIN,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:46:15,1738904329,9/15/2015 18:46:00,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,91,CALCITONIN,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:50:08,1738906517,9/15/2015 18:49:52,false,superrewards,1,33199643,USA,WI,La Crosse,138.49.2.136,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,calcitonin response to HYPERCALCEMIA seen in SCGx,136-147-156-159-173-178-181,75-85-91-102,increased basal CALCITONIN levels,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 18:57:54,1738910451,9/15/2015 18:56:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,calcitonin response to HYPERCALCEMIA,136-147-156-159,85-91-102,basal CALCITONIN levels,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 19:05:10,1738913800,9/15/2015 19:04:30,false,neodev,1,33397209,GBR,X5,Cardiff,81.105.50.218,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA SCGx,159-181,91,CALCITONIN,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747774,9/15/2015 19:14:39,1738918085,9/15/2015 19:14:03,false,neodev,1,21515166,NLD,11,Nieuwkoop,83.84.200.25,159,91,,,172,101,HYPERCALCEMIA,CALCITONIN,HYPERCALCEMIA,159,85-91-102,basal CALCITONIN levels,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats.,159,91,159,91,172,101,-1,RO-may_treat,820106,Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats,hypercalcemia,calcitonin
788747775,9/15/2015 17:22:12,1738814178,9/15/2015 17:21:55,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122,INSULIN,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:08:38,1738878279,9/15/2015 18:08:18,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122-130,INSULIN resistance,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:18:43,1738888021,9/15/2015 18:18:25,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122,INSULIN,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:23:04,1738890819,9/15/2015 18:22:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122-130,INSULIN resistance,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:25:17,1738892231,9/15/2015 18:24:46,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122,INSULIN,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:26:01,1738892532,9/15/2015 18:25:48,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122-130-151,INSULIN resistance 2,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:26:46,1738892959,9/15/2015 18:26:29,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122-130,INSULIN resistance,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:31:52,1738896037,9/15/2015 18:30:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122-130,INSULIN resistance,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:34:38,1738897810,9/15/2015 18:34:16,false,neodev,1.0,33758777,USA,"","",38.95.108.251,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"TYPE 2 DIABETES MELLITUS,",146-151-153-162,122,INSULIN,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747775,9/15/2015 18:36:38,1738899063,9/15/2015 18:36:10,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,146,122,,,170,129,TYPE 2 DIABETES MELLITUS,INSULIN,"insulin resistance with TYPE 2 DIABETES MELLITUS, hypertriglyceridemia, and obesity.",122-130-141-146-151-153-162-172-194-198,98-112-122-130-141-146-153-162-172-194-198-151,"hypertension, increased INSULIN resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.","There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity.",146 151 153 162,122,146,122,170,129,-1,RO-may_treat,820007,"There is also an increased association between OSAS and metabolic syndrome (the deadly quartet of hypertension, increased insulin resistance with type 2 diabetes mellitus, hypertriglyceridemia, and obesity",type 2 diabetes mellitus,insulin
788747776,9/15/2015 15:52:05,1738762366,9/15/2015 15:51:52,false,clixsense,1,30681826,GBR,I9,Diss,31.49.71.254,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,factors; estrogen deficiency; PREMATURE MENOPAUSE age 45);,95-104-113-125-135-153-157,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 15:58:44,1738764916,9/15/2015 15:58:17,false,elite,1.0,31883685,GBR,"","",79.66.244.188,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:00:37,1738765911,9/15/2015 16:00:17,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:03:27,1738767106,9/15/2015 16:03:13,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104,ESTROGEN,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:04:53,1738767595,9/15/2015 16:04:26,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,estrogen deficiency; PREMATURE MENOPAUSE (before age 45); prolonged secondary amenorrhea,104-113-125-135-145-153-157-162-172-182,83-90-95-104-113-125-135,strong risk factors; ESTROGEN deficiency; premature menopause,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:07:06,1738768503,9/15/2015 16:05:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:07:54,1738768828,9/15/2015 16:07:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:07:56,1738768838,9/15/2015 16:07:19,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:08:04,1738768877,9/15/2015 16:07:13,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747776,9/15/2015 16:08:48,1738769198,9/15/2015 16:08:02,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,125,104,,,144,112,PREMATURE MENOPAUSE,ESTROGEN,PREMATURE MENOPAUSE,125-135,104-113,ESTROGEN deficiency;,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the.",125 135,104,125,104,144,112,-1,RO-may_treat,820099,"Clinical risk factors providing indications for bone densitometry are: presence of strong risk factors; estrogen deficiency; premature menopause (before age 45); prolonged secondary amenorrhea (>1 year); primary hypogonadism; corticosteroid therapy (>7.5 mg/d for ≥1 year); maternal family history of hip fracture; low body mass index ( Geneva Foundation for Medical Education and Research  Osteoporosis  Provides a list of all of the available guidelines for osteoporosis around the world  International Society for Clinical Densitometry, 2007  2007 offical positions and pediatric official positions of the",premature menopause,estrogen
788747777,9/15/2015 18:11:28,1738881593,9/15/2015 18:11:05,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:21:10,1738889656,9/15/2015 18:20:38,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:27:15,1738893203,9/15/2015 18:27:01,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:28:19,1738893773,9/15/2015 18:27:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:29:13,1738894286,9/15/2015 18:29:01,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,uncomplicated URINARY TRACT INFECTIONS,241-255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:29:21,1738894407,9/15/2015 18:29:09,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:37:51,1738899783,9/15/2015 18:37:31,false,neodev,1.0,33758777,USA,"","",38.95.108.251,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:39:13,1738900581,9/15/2015 18:38:57,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,uncomplicated URINARY TRACT INFECTIONS,241-255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:45:44,1738904111,9/15/2015 18:44:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,URINARY TRACT INFECTIONS,255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747777,9/15/2015 18:48:11,1738905510,9/15/2015 18:47:53,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,255,206,,,279,220,URINARY TRACT INFECTIONS,NITROFURANTOIN,uncomplicated URINARY TRACT INFECTIONS,241-255-263-269,206,NITROFURANTOIN,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women.,255 263 269,206,255,206,279,220,-1,RO-may_prevent,820216,No statistical difference was found in the subjective and objective assessments of the response to the two medications and it is concluded that pipemidic acid is a satisfactory and effective alternative to nitrofurantoin in the treatment of uncomplicated urinary tract infections in women,urinary tract infections,nitrofurantoin
788747778,9/15/2015 16:22:26,1738774094,9/15/2015 16:22:15,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:23:22,1738774533,9/15/2015 16:23:03,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,rheumatoid arthritis and OSTEOARTHRITIS studies showed etodolac (200 300 mg b.i.d.,11-22-32-36-51-59-66-75-83-87-90,11-22-36-51-59-66-75-80-83-87-90,rheumatoid arthritis osteoarthritis studies showed ETODOLAC (200 to 300 mg b.i.d.,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:23:23,1738774540,9/15/2015 16:23:05,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:25:36,1738775403,9/15/2015 16:25:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:25:47,1738775489,9/15/2015 16:24:55,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:26:12,1738775627,9/15/2015 16:25:09,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66-75-80-83-87-90,ETODOLAC (200 to 300 mg b.i.d.,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:27:06,1738775951,9/15/2015 16:26:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,rheumatoid arthritis and OSTEOARTHRITIS studies showed etodolac (200 to 300 mg b.i.d.,11-22-32-36-51-59-66-75-80-83-87-90,11-22-32-36-51-59-66-75-80-83-87-90,rheumatoid arthritis and osteoarthritis studies showed ETODOLAC (200 to 300 mg b.i.d.,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:28:44,1738776527,9/15/2015 16:27:37,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:30:08,1738776983,9/15/2015 16:29:51,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,rheumatoid arthritis and OSTEOARTHRITIS,11-22-32-36,66-75-80-83-87-90,ETODOLAC (200 to 300 mg b.i.d.,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747778,9/15/2015 16:33:48,1738778169,9/15/2015 16:33:36,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,36,66,,,50,74,OSTEOARTHRITIS,ETODOLAC,OSTEOARTHRITIS,36,66,ETODOLAC,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d.,36,66,36,66,50,74,-1,RO-may_treat,820102,Results of rheumatoid arthritis and osteoarthritis studies showed etodolac (200 to 300 mg b.i.d,osteoarthritis,etodolac
788747779,9/15/2015 18:42:57,1738902672,9/15/2015 18:42:30,false,neodev,1.0,33758777,USA,"","",38.95.108.251,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,SEBORRHEIC DERMATITIS,107-118,148,KETOCONAZOLE,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 18:48:08,1738905450,9/15/2015 18:47:55,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,moderate to severe SEBORRHEIC DERMATITIS,88-97-100-107-118,141-148-161,plasma KETOCONAZOLE concentrations,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:08:03,1738915271,9/15/2015 19:07:41,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,SEBORRHEIC DERMATITIS,107-118,141-148-161-178-183,plasma KETOCONAZOLE concentrations 106 2%,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:11:00,1738916507,9/15/2015 19:09:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,severe SEBORRHEIC DERMATITIS,100-107-118,141-148-161,plasma KETOCONAZOLE concentrations,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:17:33,1738919311,9/15/2015 19:17:25,false,neodev,1,33895262,USA,VA,Mclean,63.141.204.167,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,moderate to severe SEBORRHEIC DERMATITIS resulted in plasma plasma,88-97-100-107-118-129-138-141-351,129-138-141-148-161-178-183-191,resulted in plasma KETOCONAZOLE concentrations 106 2% Topical,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:17:59,1738919559,9/15/2015 19:17:32,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,SEBORRHEIC DERMATITIS,107-118,141-148-161-178-183-186,plasma KETOCONAZOLE concentrations 106 2% gel:,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:26:35,1738923393,9/15/2015 19:25:56,false,tremorgames,1,32655637,CAN,ON,Markham,135.23.223.26,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,moderate to severe SEBORRHEIC DERMATITIS,88-97-100-107-118,141-148,plasma KETOCONAZOLE,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:29:54,1738924346,9/15/2015 19:29:30,false,bitcoinget,1,29516942,USA,CA,Saratoga,107.178.35.226,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,SEBORRHEIC DERMATITIS,107-118,148,KETOCONAZOLE,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:30:55,1738924652,9/15/2015 19:30:24,false,elite,1,33238902,NLD,06,Budel,77.248.148.5,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,to severe SEBORRHEIC DERMATITIS,97-100-107-118,141-148,plasma KETOCONAZOLE,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747779,9/15/2015 19:38:48,1738927255,9/15/2015 19:37:55,false,prodege,1,16101132,GBR,F9,Hayes,2.216.28.167,107,148,,,128,160,SEBORRHEIC DERMATITIS,KETOCONAZOLE,SEBORRHEIC DERMATITIS,107-118,141-148,plasma KETOCONAZOLE,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14.",107 118,148,107,148,128,160,-1,RO-may_treat,820023,"56 ,   63  2% foam: Topical application of 3 g twice daily for 4 weeks in patients with moderate to severe seborrheic dermatitis resulted in plasma ketoconazole concentrations   106  2% gel: Topical application once daily for 2 weeks (0.05-3.47 g daily) in patients with severe seborrheic dermatitis (1-14% of body surface area) resulted in mean peak plasma concentrations of 1.35 ng/mL on day 7 and 0.8 ng/mL on day 14",seborrheic dermatitis,ketoconazole
788747780,9/15/2015 16:32:01,1738777586,9/15/2015 16:31:48,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:37:43,1738779545,9/15/2015 16:37:32,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"With HYPOTHYROIDISM, pursue treatment cautiously; start with small TSH",0-5-21-28-38-50-56-61-116,21-61-67-73-76-90-94-102-28,pursue treatment small doses of LEVOTHYROXINE and closely monitor,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:41:03,1738781147,9/15/2015 16:40:50,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:43:32,1738782545,9/15/2015 16:43:18,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:47:41,1738785919,9/15/2015 16:47:11,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:48:00,1738786122,9/15/2015 16:47:48,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:55:14,1738792310,9/15/2015 16:55:09,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"With HYPOTHYROIDISM, pursue treatment cautiously; with",0-5-21-28-38-56,61-67-73-76-90-94-102-50,start small doses of LEVOTHYROXINE and closely monitor,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 16:56:16,1738793196,9/15/2015 16:55:55,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 17:11:30,1738808271,9/15/2015 17:11:10,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"With HYPOTHYROIDISM, pursue treatment cautiously; monitor serum TSH values.",0-5-21-28-38-102-110-116-120,61-67-73-76-90-94-102-110-116-120,small doses of LEVOTHYROXINE and closely monitor serum TSH values.,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747780,9/15/2015 17:15:16,1738810815,9/15/2015 17:14:58,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,5,76,,,19,89,HYPOTHYROIDISM,LEVOTHYROXINE,"HYPOTHYROIDISM,",5,76,LEVOTHYROXINE,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values.",5,76,5,76,19,89,-1,RO-may_prevent,820221,"With hypothyroidism, pursue treatment cautiously; start with small doses of levothyroxine and closely monitor serum TSH values",hypothyroidism,levothyroxine
788747781,9/15/2015 16:25:13,1738775273,9/15/2015 16:25:03,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:28:56,1738776599,9/15/2015 16:28:40,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"causative agent of DIPHTHERIA,",33-43-49-52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:33:39,1738778123,9/15/2015 16:32:59,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:36:02,1738778888,9/15/2015 16:35:49,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"causative agent of DIPHTHERIA, utilizes various host compounds iron.",33-43-49-52-64-73-81-86-107,0-16-29-33-43-86-52,"CORYNEBACTERIUM DIPHTHERIAE, the causative agent diphtheria, compounds","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:37:27,1738779447,9/15/2015 16:37:17,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"causative agent of DIPHTHERIA,",33-43-49-52,0-16-29-33-43,"CORYNEBACTERIUM DIPHTHERIAE, the causative agent","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:38:41,1738780009,9/15/2015 16:38:04,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:39:48,1738780499,9/15/2015 16:39:27,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16-29-33-43-49-52,"CORYNEBACTERIUM DIPHTHERIAE, the causative agent of diphtheria,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:45:44,1738784483,9/15/2015 16:45:29,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:53:30,1738790479,9/15/2015 16:53:08,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"Corynebacterium diphtheriae, causative agent of DIPHTHERIA, utilizes various host",0-33-43-49-52-64-73-81-16,0-16-29-33-43-64-73,"CORYNEBACTERIUM DIPHTHERIAE, the causative agent utilizes various","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747781,9/15/2015 16:53:51,1738790747,9/15/2015 16:53:14,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,52,0,,,62,27,DIPHTHERIA,CORYNEBACTERIUM DIPHTHERIAE,"DIPHTHERIA,",52,0-16,"CORYNEBACTERIUM DIPHTHERIAE,","Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron.",52,0 16,52,0,62,27,-1,RO-may_prevent,820190,"Corynebacterium diphtheriae, the causative agent of diphtheria, utilizes various host compounds to acquire iron",diphtheria,Corynebacterium diphtheriae
788747782,9/15/2015 16:39:54,1738780559,9/15/2015 16:39:41,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,108,21,,,114,30,ZOSTER,ACYCLOVIR,herpes simplex and varicella ZOSTER virus infections.,86-94-98-108-115-121-79,0-5-21-31-35-45-57-9,Oral and intravenous ACYCLOVIR are effective in initial,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 16:46:35,1738785097,9/15/2015 16:46:11,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,108,21,,,114,30,ZOSTER,ACYCLOVIR,varicella ZOSTER virus,98-108-115,21,ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 16:50:35,1738787853,9/15/2015 16:50:15,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,108,21,,,114,30,ZOSTER,ACYCLOVIR,varicella ZOSTER virus infections.,98-108-115-121,0-5-9-21,Oral and intravenous ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 16:55:05,1738792137,9/15/2015 16:54:12,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,108,21,,,114,30,ZOSTER,ACYCLOVIR,varicella ZOSTER virus infections.,98-108-115-121,21,ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 17:13:33,1738809776,9/15/2015 17:13:21,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,108,21,,,114,30,ZOSTER,ACYCLOVIR,herpes simplex and varicella ZOSTER virus infections.,86-94-98-108-115-121-79,0-5-9-21-31-35-45-48-57-65-69-79,Oral and intravenous ACYCLOVIR are effective in treating initial and recurrent herpes,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 17:18:02,1738812073,9/15/2015 17:17:39,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,108,21,,,114,30,ZOSTER,ACYCLOVIR,ZOSTER,108,21,ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 17:30:49,1738819183,9/15/2015 17:30:31,false,clixsense,1,28352278,GBR,P4,Newbury,81.158.243.105,108,21,,,114,30,ZOSTER,ACYCLOVIR,simplex and varicella ZOSTER virus infections.,86-98-108-115-121-94,0-9-21-5,Oral and intravenous ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 17:53:54,1738860775,9/15/2015 17:53:49,false,neodev,1,33238512,NLD,11,Delft,94.210.42.212,108,21,,,114,30,ZOSTER,ACYCLOVIR,simplex and varicella ZOSTER virus infections.,86-94-98-108-115-121,0-5-9-21-31-35-45,Oral and intravenous ACYCLOVIR are effective in,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 18:04:28,1738873230,9/15/2015 18:03:47,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,108,21,,,114,30,ZOSTER,ACYCLOVIR,varicella ZOSTER virus,98-108-115,9-21,intravenous ACYCLOVIR,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747782,9/15/2015 18:05:25,1738874310,9/15/2015 18:05:21,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,108,21,,,114,30,ZOSTER,ACYCLOVIR,simplex and varicella ZOSTER virus infections.,86-94-98-108-115-121,0-5-9-21-31-35-45,Oral and intravenous ACYCLOVIR are effective in,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections.,108,21,108,21,114,30,-1,RO-may_prevent,820340,Oral and intravenous acyclovir are effective in treating initial and recurrent herpes simplex and varicella-zoster virus infections,zoster,acyclovir
788747783,9/15/2015 16:22:13,1738773996,9/15/2015 16:21:55,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,135,65,,,141,74,CAVITY,F ELEMENT,"CAVITY,",135,65-67,F ELEMENT,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:23:02,1738774359,9/15/2015 16:22:32,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY, thus providing the first inclusion tetrahedral oxoanion in this macrocycle.",131-135-143-148-158-162-176-191-203-212-215-220,52-54-62-65-67-75-81-85-89-100-106-109,") bonding to F ELEMENT ions, but the perrhenate bound to Ln","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:23:04,1738774370,9/15/2015 16:22:32,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY,",131-135,65-67,F ELEMENT,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:24:53,1738775167,9/15/2015 16:24:26,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY,",131-135,52-65-67,) F ELEMENT,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:25:08,1738775257,9/15/2015 16:24:50,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY,",131-135,46-52-54-62-65-67-75,"ReO4( ) bonding to F ELEMENT ions,","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:25:19,1738775309,9/15/2015 16:24:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY,",131-135,65-67-75,"F ELEMENT ions,","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:26:37,1738775747,9/15/2015 16:25:53,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,135,65,,,141,74,CAVITY,F ELEMENT,"in the CB6 CAVITY, thus providing the",124-127-131-135-143-148-158,54-62-65-67-75-81-85-89-100-106-109-112-115-124-127-131-135,"bonding to F ELEMENT ions, but the perrhenate bound to Ln is included in the CB6 cavity,","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:27:34,1738776117,9/15/2015 16:26:09,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,135,65,,,141,74,CAVITY,F ELEMENT,"CB6 CAVITY,",131-135,65-67-75,"F ELEMENT ions,","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:29:51,1738776907,9/15/2015 16:28:48,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,135,65,,,141,74,CAVITY,F ELEMENT,"perrhenate bound to Ln is included in CB6 CAVITY,",89-100-106-109-112-115-131-135-124,46-51-52-54-62-65-67-75,"ReO4( - ) bonding to F ELEMENT ions,","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747783,9/15/2015 16:33:46,1738778150,9/15/2015 16:33:33,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,135,65,,,141,74,CAVITY,F ELEMENT,"in the CB6 CAVITY, thus providing the first case",124-127-131-135-143-148-158-162-168,52-54-62-65-67-75-81-85-89,") bonding to F ELEMENT ions, but the perrhenate","Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle.",135,65 67,135,65,141,74,-1,RO-may_prevent,820207,"Not only are these complexes rare examples of ReO4(-) bonding to f element ions, but the perrhenate bound to Ln is included in the CB6 cavity, thus providing the first case of inclusion of a tetrahedral oxoanion in this macrocycle",cavity,f element
788747784,9/15/2015 16:25:47,1738775495,9/15/2015 16:25:30,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B,30-40,50-60,(HBV) HBSAG,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:29:57,1738776937,9/15/2015 16:29:42,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions (HBV),30-40-42-50,60-66,HBSAG particles,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:35:21,1738778682,9/15/2015 16:34:08,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions (HBV),30-40-42-50,60,HBSAG,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:36:31,1738779126,9/15/2015 16:36:18,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,30,60,,,41,65,HEPATITIS B,HBSAG,evidence suggests that HEPATITIS B virions (HBV) and,7-16-25-30-40-42-56-50,42-50-56-60-66-76-84-94-98,virions (HBV) and HBSAG particles contain receptors for polymerized,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:40:58,1738781090,9/15/2015 16:40:30,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions (HBV),30-40-50-42,60-66,HBSAG particles,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:41:14,1738781195,9/15/2015 16:40:11,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions (HBV),30-40-42-50,60-66,HBSAG particles,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:46:32,1738785054,9/15/2015 16:46:08,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions (HBV),30-40-42-50,60,HBSAG,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:54:00,1738790918,9/15/2015 16:53:49,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B virions and HBsAg (pHSA.,30-40-42-56-60-130,42-50-56-60-66-76-84-130,virions (HBV) and HBSAG particles contain receptors (pHSA.,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 16:54:26,1738791402,9/15/2015 16:54:06,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,30,60,,,41,65,HEPATITIS B,HBSAG,HEPATITIS B,30-40,60,HBSAG,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747784,9/15/2015 17:10:10,1738807054,9/15/2015 17:09:56,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,30,60,,,41,65,HEPATITIS B,HBSAG,evidence suggests that HEPATITIS B virions and HBsAg,7-16-25-30-40-42-56-60,30-42-50-56-60-66-76-84-40,hepatitis B virions (HBV) and HBSAG particles contain receptors,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA.,30 40,60,30,60,41,65,-1,RO-may_prevent,820157,Recent evidence suggests that hepatitis B virions (HBV) and HBsAg particles contain receptors for polymerized human serum albumin (pHSA,hepatitis B,HBsAg
788747785,9/15/2015 16:31:45,1738777498,9/15/2015 16:31:27,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Ximelagatran,276-283-297,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:37:30,1738779448,9/15/2015 16:37:15,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,susceptibility heart failure and ATRIAL FIBRILLATION Ximelagatran vs warfarin for stroke prevention patients,240-258-264-272-276-283-297-310-313-322-326-333-347,283-297-310-313-322-326-333-361-347,fibrillation Ximelagatran vs WARFARIN for stroke prevention patients nonvalvular,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:40:49,1738781038,9/15/2015 16:39:34,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Ximelagatran,276-283-297,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:43:17,1738782361,9/15/2015 16:42:29,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Ximelagatran,276-283-297,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:47:10,1738785515,9/15/2015 16:46:13,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Ximelagatran,276-283-297,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:47:47,1738785988,9/15/2015 16:47:20,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,276-283,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:55:07,1738792183,9/15/2015 16:54:54,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,susceptibility heart failure and ATRIAL FIBRILLATION Ximelagatran vs warfarin surgery randomized,240-258-264-272-276-283-297-310-313-565-611,283-297-310-313-322-326-333-622-611,fibrillation Ximelagatran vs WARFARIN for stroke prevention randomized controlled,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 16:55:54,1738792893,9/15/2015 16:55:43,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,276-283,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 17:11:09,1738807913,9/15/2015 17:10:54,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,heart failure and ATRIAL FIBRILLATION Ximelagatran vs warfarin for stroke prevention,258-264-272-276-283-297-310-313-322-326-333,258-264-272-283-297-310-313-322-326-333-276,heart failure and atrial fibrillation Ximelagatran vs WARFARIN for stroke prevention,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747785,9/15/2015 17:14:57,1738810621,9/15/2015 17:14:27,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,276,313,,,295,321,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,276-283,313,WARFARIN,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.,276 283,313,276,313,295,321,-1,RO-may_treat,820042,A multicenter risk index for atrial fibrillation after cardiac surgery  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring  Obesity and the risk of new-onset atrial fibrillation  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial  Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial,atrial fibrillation,warfarin
788747786,9/15/2015 18:23:27,1738891025,9/15/2015 18:23:14,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:29:37,1738894557,9/15/2015 18:29:25,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:30:57,1738895411,9/15/2015 18:30:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:32:10,1738896191,9/15/2015 18:31:54,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:40:58,1738901664,9/15/2015 18:40:39,false,neodev,1.0,33758777,USA,"","",38.95.108.251,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:46:30,1738904480,9/15/2015 18:46:16,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,36-40-55,new ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:50:21,1738906688,9/15/2015 18:50:09,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,knowledge about ARRHYTHMIAS and new antiarrhythmic,4-20-32-36-40-14,20-32-36-40-55-61-69-77,arrhythmias and new ANTIARRHYTHMIC DRUGS provide greater opportunities,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 18:59:16,1738911052,9/15/2015 18:57:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 19:05:32,1738913978,9/15/2015 19:05:11,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747786,9/15/2015 19:14:01,1738917794,9/15/2015 19:11:46,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,20,40,,,31,60,ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,ARRHYTHMIAS,20,40-55,ANTIARRHYTHMIC DRUGS,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations.,20,40 55,20,40,31,60,-1,RO-may_prevent,820206,New knowledge about arrhythmias and new antiarrhythmic drugs provide greater opportunities for treatment choice and evaluations,arrhythmias,antiarrhythmic drugs
788747787,9/15/2015 18:13:16,1738883615,9/15/2015 18:13:03,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS,70-75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:22:43,1738890592,9/15/2015 18:22:31,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,75,134,,,82,147,ABSCESS,METRONIDAZOLE,ABSCESS,75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:28:52,1738894024,9/15/2015 18:28:37,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,75,134,,,82,147,ABSCESS,METRONIDAZOLE,ABSCESS,75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:30:09,1738894944,9/15/2015 18:29:51,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS,70-75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:31:16,1738895649,9/15/2015 18:31:00,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS,70-75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:39:58,1738901023,9/15/2015 18:39:36,false,neodev,1.0,33758777,USA,"","",38.95.108.251,75,134,,,82,147,ABSCESS,METRONIDAZOLE,ABSCESS,75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:41:15,1738901814,9/15/2015 18:40:38,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,75,134,,,82,147,ABSCESS,METRONIDAZOLE,patients with lung ABSCESS necrotizing pneumonia pneumonia with empyema,56-65-70-75-94-106-214-224-229,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:49:40,1738906258,9/15/2015 18:49:27,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS and 1 with,70-75-83-87-89,116-121-129-134,were treated with METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 18:54:42,1738908878,9/15/2015 18:52:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS,70-75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747787,9/15/2015 19:04:22,1738913336,9/15/2015 19:04:02,false,zoombucks,1,4688131,CAN,BC,Vancouver,216.251.132.22,75,134,,,82,147,ABSCESS,METRONIDAZOLE,lung ABSCESS,70-75,134,METRONIDAZOLE,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin.",75,134,75,134,82,147,-1,RO-may_treat,820047,"• In a randomized study of anaerobic lung infections, 6 patients with lung abscess and 1 with necrotizing pneumonia were treated with metronidazole and 6 with lung abscess, 3 with necrotizing pneumonia, and 1 with pneumonia with empyema were treated with clindamycin",abscess,metronidazole
788747788,9/15/2015 16:21:53,1738773811,9/15/2015 16:21:39,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,124-131,85,WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:22:30,1738774121,9/15/2015 16:22:14,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,non valvular ATRIAL FIBRILLATION (SPORTIF III): randomised,111-115-124-131-153-159-144,48-58-71-80-85-94-97-106-111-115-124-131-144-153,inhibitor ximelagatran compared with WARFARIN in patients with non valvular atrial fibrillation (SPORTIF III):,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:22:31,1738774122,9/15/2015 16:22:10,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,124-131,85,WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:24:25,1738775001,9/15/2015 16:23:41,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,124-131,85,WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:24:49,1738775140,9/15/2015 16:24:33,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,non valvular ATRIAL FIBRILLATION (SPORTIF III):,111-115-124-131-144-153,85,WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:24:58,1738775201,9/15/2015 16:22:17,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,non valvular ATRIAL FIBRILLATION randomised,111-115-124-131-159,85-106,WARFARIN with,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:25:51,1738775531,9/15/2015 16:25:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,with non valvular ATRIAL FIBRILLATION (SPORTIF III): randomised,106-111-115-124-131-153-159-144,58-71-80-85-94-97-106-111-115-124-131,ximelagatran compared with WARFARIN in patients with non valvular atrial fibrillation,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:26:06,1738775605,9/15/2015 16:24:49,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,non valvular ATRIAL FIBRILLATION,111-115-124-131,85,WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:28:47,1738776545,9/15/2015 16:28:17,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,non valvular ATRIAL FIBRILLATION,111-115-124-131,39-48-58-71-80-85,thrombin inhibitor ximelagatran compared with WARFARIN,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747788,9/15/2015 16:33:33,1738778096,9/15/2015 16:33:20,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,124,85,,,143,93,ATRIAL FIBRILLATION,WARFARIN,ximelagatran with non valvular ATRIAL FIBRILLATION III): randomised,106-111-115-124-131-153-159-58,58-71-80-85-94-97-106-131,ximelagatran compared with WARFARIN in patients with fibrillation,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.,124 131,85,124,85,143,93,-1,RO-may_treat,820063,Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial,atrial fibrillation,warfarin
788747789,9/15/2015 18:43:21,1738902865,9/15/2015 18:43:02,false,neodev,1.0,33758777,USA,"","",38.95.108.251,81,56,,,85,65,PAIN,IBUPROFEN,PAIN,81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 18:48:23,1738905609,9/15/2015 18:48:09,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,81,56,,,85,65,PAIN,IBUPROFEN,PAIN,81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:08:34,1738915502,9/15/2015 19:08:04,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,81,56,,,85,65,PAIN,IBUPROFEN,PAIN residual needle pain,81-90-99-111,20-29-43-53-56,"pain significantly decreased by IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:18:34,1738919918,9/15/2015 19:18:00,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,81,56,,,85,65,PAIN,IBUPROFEN,memory of PAIN,71-78-81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:26:55,1738923602,9/15/2015 19:26:36,false,tremorgames,1.0,32655637,CAN,ON,Markham,135.23.223.26,81,56,,,85,65,PAIN,IBUPROFEN,PAIN,81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:30:27,1738924500,9/15/2015 19:29:54,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,81,56,,,85,65,PAIN,IBUPROFEN,PAIN,81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:31:52,1738924925,9/15/2015 19:30:57,false,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,81,56,,,85,65,PAIN,IBUPROFEN,PAIN and residual needle site pain,81-86-90-99-106-111,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:39:23,1738927450,9/15/2015 19:38:49,false,prodege,1.0,16101132,GBR,F9,Hayes,2.216.28.167,81,56,,,85,65,PAIN,IBUPROFEN,PAIN,81,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:39:51,1738927569,9/15/2015 19:38:22,false,instagc,1,31157999,USA,KS,Topeka,68.102.220.35,81,56,,,85,65,PAIN,IBUPROFEN,memory of PAIN and residual needle,71-78-81-86-90-99,56,"IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747789,9/15/2015 19:46:43,1738930147,9/15/2015 19:45:17,false,pocketmoneygpt,1,34458129,USA,CA,Lake Forest,158.69.137.23,81,56,,,85,65,PAIN,IBUPROFEN,memory of PAIN,71-78-81,0-10-17-20-25-29-43-53-56,"Immediate recall of pain was significantly decreased by IBUPROFEN,","Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased.",81,56,81,56,85,65,-1,RO-may_prevent,820250,"Immediate recall of pain was significantly decreased by ibuprofen, but memory of pain and residual needle site pain a day after EMG were not decreased",pain,ibuprofen
788747790,9/15/2015 18:30:06,1738894887,9/15/2015 18:29:54,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 18:32:48,1738896485,9/15/2015 18:32:28,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210-220,"DIGITALIS use,","Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 18:41:39,1738902026,9/15/2015 18:41:18,false,neodev,1.0,33758777,USA,"","",38.95.108.251,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 18:47:20,1738905028,9/15/2015 18:47:01,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:04:44,1738913499,9/15/2015 19:01:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:06:44,1738914638,9/15/2015 19:06:14,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:16:14,1738918740,9/15/2015 19:15:09,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"or ATRIAL FIBRILLATION,",161-189-196,210-220,"DIGITALIS use,","Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:16:55,1738919030,9/15/2015 19:16:44,false,neodev,1.0,33895262,USA,VA,Mclean,63.141.204.167,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"or cardiac transplantation, ATRIAL FIBRILLATION, digitalis use, pacemaker disease.",161-164-172-189-196-210-220-225-282,172-189-196-210-220-225-235-96,"cardiomyopathy, transplantation, atrial fibrillation, DIGITALIS use, pacemaker or","Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:20:40,1738920984,9/15/2015 19:20:04,false,fusioncash,1,20623511,USA,OH,Cleveland,99.126.168.235,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747790,9/15/2015 19:24:29,1738922592,9/15/2015 19:23:28,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,189,210,,,208,219,ATRIAL FIBRILLATION,DIGITALIS,"ATRIAL FIBRILLATION,",189-196,210,DIGITALIS,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease.",189 196,210,189,210,208,219,-1,RO-may_treat,820065,"Exclusion criteria were coronary disease, heart failure, left ventricular systolic dysfunction, cardiomyopathy, valvular or congenital heart disease, past renal or cardiac transplantation, atrial fibrillation, digitalis use, pacemaker or defibrillator placement, or end-stage renal disease",atrial fibrillation,digitalis
788747791,9/15/2015 18:11:54,1738882099,9/15/2015 18:11:29,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA Prevention,22-32,0-7,NIACIN Deficiency,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:21:27,1738889846,9/15/2015 18:21:11,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA,22,0,NIACIN,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:27:27,1738893341,9/15/2015 18:27:16,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA,22,0,NIACIN,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:28:36,1738893901,9/15/2015 18:28:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA Prevention of niacin deficiency.,22-32-43-46-53,0-7,NIACIN Deficiency,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:29:23,1738894437,9/15/2015 18:29:14,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA Prevention,22-32,0-7,NIACIN Deficiency,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:29:39,1738894561,9/15/2015 18:29:24,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA,22,0-7,NIACIN Deficiency,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:38:08,1738899896,9/15/2015 18:37:53,false,neodev,1.0,33758777,USA,"","",38.95.108.251,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA,22,0,NIACIN,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:39:31,1738900779,9/15/2015 18:39:13,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,22,0,,,30,6,PELLAGRA,NIACIN,Niacin Deficiency PELLAGRA niacin deficiency.,0-7-22-46-53,0-7-18-22,NIACIN Deficiency and Pellagra,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:47:06,1738904878,9/15/2015 18:45:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,22,0,,,30,6,PELLAGRA,NIACIN,PELLAGRA,22,0-7,NIACIN Deficiency,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747791,9/15/2015 18:48:23,1738905612,9/15/2015 18:48:12,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,22,0,,,30,6,PELLAGRA,NIACIN,Niacin Deficiency and PELLAGRA Prevention of niacin deficiency.,0-7-18-22-32-43-46-53,0-7-18-22-46-53-32,NIACIN Deficiency and Pellagra Prevention niacin deficiency.,Niacin Deficiency and Pellagra  Prevention of niacin deficiency.,22,0,22,0,30,6,-1,RO-may_treat,820033,Niacin Deficiency and Pellagra  Prevention of niacin deficiency,Pellagra,Niacin
788747792,9/15/2015 16:19:41,1738773097,9/15/2015 16:19:26,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:21:06,1738773534,9/15/2015 16:20:53,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:21:21,1738773627,9/15/2015 16:21:02,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,Using 2 chloroprocaine can diminish PAIN caused by the intradermal injection of lidocaine.,14-20-22-37-41-50-55-62-65-69-81-94-91,14-20-22-37-41-50,Using 2 CHLOROPROCAINE can diminish pain,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:21:29,1738773647,9/15/2015 16:21:13,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:21:41,1738773723,9/15/2015 16:21:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:22:34,1738774138,9/15/2015 16:22:06,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:23:44,1738774694,9/15/2015 16:22:38,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:23:58,1738774821,9/15/2015 16:23:44,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN,50,20-22,2 CHLOROPROCAINE,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:24:02,1738774851,9/15/2015 16:23:46,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,chloroprocaine can diminish PAIN caused by the intradermal injection of lidocaine.,22-37-41-50-55-62-65-69-81-91-94,0-14-20-22-37-41-50-55-62-65-69-81-91-94,IMPLICATIONS: Using 2 CHLOROPROCAINE can diminish pain caused by the intradermal injection of lidocaine.,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747792,9/15/2015 16:27:42,1738776157,9/15/2015 16:27:10,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,50,20,,,54,36,PAIN,2-CHLOROPROCAINE,PAIN caused by the intradermal injection of lidocaine.,50-55-62-65-69-81-91-94,14-20-22-37-41-50,Using 2 CHLOROPROCAINE can diminish pain,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine.,50,20 22,50,20,54,36,-1,RO-may_prevent,820294,IMPLICATIONS: Using 2-chloroprocaine can diminish pain caused by the intradermal injection of lidocaine,pain,2-chloroprocaine
788747793,9/15/2015 16:24:48,1738775139,9/15/2015 16:24:38,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,84,DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:26:05,1738775596,9/15/2015 16:25:56,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,treatment of IRON OVERLOAD are deferoxamine and deferiprone.,53-63-66-71-80-84-97-101,53-66-71-80-84-97-101-63,treatment of iron overload are DEFEROXAMINE and deferiprone.,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:28:17,1738776414,9/15/2015 16:28:03,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,84,DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:32:19,1738777673,9/15/2015 16:31:08,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,84,DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:35:34,1738778727,9/15/2015 16:35:22,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,available the treatment of IRON OVERLOAD are deferoxamine and,49-53-63-66-71-80-84-97-35,45-53-66-71-80-84-97-101-35,available for treatment iron overload are DEFEROXAMINE and deferiprone.,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:36:51,1738779243,9/15/2015 16:36:24,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,the treatment of IRON OVERLOAD,49-53-63-66-71,53-63-66-71-84-97-101-80,treatment of iron overload are DEFEROXAMINE and deferiprone.,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:37:22,1738779439,9/15/2015 16:36:45,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,84,DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:38:55,1738780118,9/15/2015 16:38:23,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,13-18-28-84,iron chelating agents DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:45:05,1738784036,9/15/2015 16:44:50,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,IRON OVERLOAD,66-71,84,DEFEROXAMINE,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747793,9/15/2015 16:52:48,1738789874,9/15/2015 16:52:28,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,66,84,,,79,96,IRON OVERLOAD,DEFEROXAMINE,the treatment of IRON OVERLOAD are deferoxamine and deferiprone.,49-53-63-66-71-80-84-97-101,66-71-80-84-97-101-53,treatment iron overload are DEFEROXAMINE and deferiprone.,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone.,66 71,84,66,84,79,96,-1,RO-may_prevent,820339,The only two iron chelating agents available for the treatment of iron overload are deferoxamine and deferiprone,iron overload,deferoxamine
788747794,9/15/2015 17:22:28,1738814337,9/15/2015 17:22:12,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:09:01,1738878762,9/15/2015 18:08:39,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:19:02,1738888231,9/15/2015 18:18:44,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:23:35,1738891145,9/15/2015 18:23:06,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:25:33,1738892313,9/15/2015 18:25:18,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:26:15,1738892652,9/15/2015 18:26:03,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,serious DECOMPRESSION SICKNESS,135-143-157,66-70,50% HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:27:04,1738893162,9/15/2015 18:26:47,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:34:05,1738897377,9/15/2015 18:31:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,66-70,50% HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:34:59,1738898049,9/15/2015 18:34:39,false,neodev,1.0,33758777,USA,"","",38.95.108.251,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,DECOMPRESSION SICKNESS,143-157,70,HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747794,9/15/2015 18:36:56,1738899227,9/15/2015 18:36:39,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,143,70,,,165,76,DECOMPRESSION SICKNESS,HELIUM,serious DECOMPRESSION SICKNESS and gas embolism,135-143-157-166-170-174,66-70,50% HELIUM,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis.",143 157,70,143,70,165,76,-1,RO-may_prevent,820314,"Recompression to 4 ata and the use of a mixture of 50% oxygen and 50% helium offers a good working compromise in the treatment of both serious decompression sickness and gas embolism arising in air diving, avoiding the need for a differential diagnosis",decompression sickness,helium
788747795,9/15/2015 18:42:28,1738902439,9/15/2015 18:42:04,false,neodev,1.0,33758777,USA,"","",38.95.108.251,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,87-93,121,(HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 18:47:54,1738905337,9/15/2015 18:47:41,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen,87-93-103-105-113,105-113-121,surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:07:40,1738915069,9/15/2015 19:07:12,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B,87-93-103,105-113-121,surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:09:37,1738915956,9/15/2015 19:06:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen,87-93-103-105-113,105-113-121,surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:17:23,1738919241,9/15/2015 19:17:13,false,neodev,1.0,33895262,USA,VA,Mclean,63.141.204.167,87,122,,,102,127,SERUM HEPATITIS,HBSAG,were negative for SERUM HEPATITIS B surface antigen linked,69-74-83-87-93-103-105-113-139,105-113-121-129-132-139-74,negative surface antigen (HBSAG) by enzyme linked,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:17:31,1738919289,9/15/2015 19:16:51,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen (HBsAg),87-93-103-105-113-121,93-103-105-113-121,hepatitis B surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:21:22,1738921330,9/15/2015 19:20:56,false,fusioncash,1.0,20623511,USA,OH,Cleveland,99.126.168.235,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,87-93,113-121,antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:25:56,1738923110,9/15/2015 19:25:04,false,tremorgames,1.0,32655637,CAN,ON,Markham,135.23.223.26,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B,87-93-103,105-113-121,surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:29:29,1738924288,9/15/2015 19:28:51,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B,87-93-103,105-113,surface antigen,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747795,9/15/2015 19:30:22,1738924486,9/15/2015 19:29:31,false,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,87,122,,,102,127,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen (HBsAg),87-93-103-105-113-121,93-103-105-113-121,hepatitis B surface antigen (HBSAG),The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay.,87 93,,87,122,102,127,-1,RO-may_prevent,820251,The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay,serum hepatitis,HBsAg
788747796,9/15/2015 16:39:40,1738780442,9/15/2015 16:39:26,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM was defined as stimulating hormone and,0-15-19-27-56-82-44,19-27-30-36-44-56-86-90,defined as serum THYROID stimulating hormone low triiodothyronine,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 16:46:10,1738784695,9/15/2015 16:45:54,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,30-36-44-56-64,serum THYROID stimulating hormone (TSH),Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 16:50:13,1738787615,9/15/2015 16:49:59,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,36-44-56,THYROID stimulating hormone,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 16:54:11,1738791097,9/15/2015 16:53:15,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,30-36-44-56,serum THYROID stimulating hormone,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 16:58:31,1738795258,9/15/2015 16:58:22,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,36,THYROID,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 17:13:19,1738809645,9/15/2015 17:13:04,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM was defined as serum thyroid stimulating hormone (TSH),0-15-19-27-30-36-44-56-64,0-19-27-30-36-44-56-15,Hypothyroidism was defined as serum THYROID stimulating hormone,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 17:17:37,1738811946,9/15/2015 17:17:22,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,36,THYROID,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 17:30:30,1738818892,9/15/2015 17:30:19,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,36-44-56-30,serum THYROID stimulating hormone,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 17:44:43,1738839525,9/15/2015 17:44:34,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,0,36,THYROID,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747796,9/15/2015 17:53:46,1738860464,9/15/2015 17:53:11,false,neodev,1.0,33238512,NLD,11,Delft,94.210.42.212,0,36,,,14,43,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM was defined as,0-15-19-27,19-27-30-36-44-56,defined as serum THYROID stimulating hormone,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels.,0,36,0,36,14,43,-1,RO-may_prevent,820357,Hypothyroidism was defined as serum thyroid-stimulating hormone (TSH) > 4.25 U/mL and low triiodothyronine (T3) state was defined as T3 levels,Hypothyroidism,thyroid
788747797,9/15/2015 16:33:28,1738778062,9/15/2015 16:32:43,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,25-35-42-45,nocturnal dosage of CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 16:38:38,1738780003,9/15/2015 16:38:24,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,the treatment of DUODENAL ULCER as a twice daily dosage,75-79-89-92-101-107-110-112-118-124,25-35-42-45-56-59-62-101-131-79,nocturnal dosage of CIMETIDINE is as effective treatment ulcer in,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 16:45:02,1738783977,9/15/2015 16:44:40,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 16:49:03,1738786798,9/15/2015 16:48:47,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 16:49:45,1738787254,9/15/2015 16:49:15,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 16:57:39,1738794495,9/15/2015 16:57:07,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 17:12:21,1738809046,9/15/2015 17:12:08,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,the treatment of DUODENAL ULCER as a twice daily dosage,75-79-89-92-101-107-110-112-118-124,25-35-42-45-56-59-62-72-75-79-89-92-101,nocturnal dosage of CIMETIDINE is as effective in the treatment of duodenal ulcer,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 17:16:24,1738811333,9/15/2015 17:16:04,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 17:29:32,1738818127,9/15/2015 17:29:19,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747797,9/15/2015 17:43:21,1738836766,9/15/2015 17:42:42,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,92,45,,,106,55,DUODENAL ULCER,CIMETIDINE,DUODENAL ULCER,92-101,45,CIMETIDINE,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population.,92 101,45,92,45,106,55,-1,RO-may_prevent,820258,A more convenient single nocturnal dosage of cimetidine is as effective in the treatment of duodenal ulcer as a twice daily dosage in the Indian population,duodenal ulcer,cimetidine
788747798,9/15/2015 16:07:24,1738768640,9/15/2015 16:07:10,false,elite,1.0,31883685,GBR,"","",79.66.244.188,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:12:00,1738770230,9/15/2015 16:11:39,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:15:12,1738771510,9/15/2015 16:14:52,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,100,153,,,104,161,PAIN,PROPOFOL,higher incidence of PAIN on injection while lignocaine to propofol,80-87-97-100-105-108-118-139-150-153,136-139-150-153-162-170,1% lignocaine to PROPOFOL reduces pain.,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:16:07,1738771769,9/15/2015 16:15:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:17:24,1738772205,9/15/2015 16:16:27,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:19:06,1738772836,9/15/2015 16:18:45,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:19:10,1738772847,9/15/2015 16:18:55,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:19:15,1738772876,9/15/2015 16:18:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:19:34,1738773061,9/15/2015 16:19:22,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,100,153,,,104,161,PAIN,PROPOFOL,higher incidence of PAIN on injection,80-87-97-100-105-108,136-139-150-153-162-170,1% lignocaine to PROPOFOL reduces pain.,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747798,9/15/2015 16:20:09,1738773255,9/15/2015 16:19:18,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,100,153,,,104,161,PAIN,PROPOFOL,PAIN,100,153,PROPOFOL,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain.,100,153,100,153,104,161,-1,RO-may_prevent,820239,A higher partition of propofol in the aqueous phase of the preparation causes a higher incidence of pain on injection while addition of 1% lignocaine to propofol reduces pain,pain,propofol
788747799,9/15/2015 16:08:15,1738768961,9/15/2015 16:08:02,false,elite,1.0,31883685,GBR,"","",79.66.244.188,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125-135,QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:14:17,1738771134,9/15/2015 16:13:49,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,"refractory, recurrent, VENTRICULAR TACHYCARDIA associated with quinidine therapy.",62-74-85-97-109-120-125-135,74-85-97-109-120-125-135-62,"refractory, recurrent, ventricular tachycardia associated with QUINIDINE therapy.","Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:16:29,1738771911,9/15/2015 16:16:12,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA associated with quinidine therapy.,85-97-109-120-125-135,97-109-120-125-135-85,ventricular tachycardia associated with QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:17:11,1738772156,9/15/2015 16:16:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125,QUINIDINE,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:18:30,1738772646,9/15/2015 16:18:16,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125-135,QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:19:55,1738773182,9/15/2015 16:19:42,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125,QUINIDINE,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:20:05,1738773220,9/15/2015 16:19:47,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125,QUINIDINE,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:20:21,1738773294,9/15/2015 16:20:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125-135,QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:20:25,1738773325,9/15/2015 16:20:09,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,"refractory, recurrent, VENTRICULAR TACHYCARDIA associated with quinidine therapy.",62-74-85-97-109-120-125-135,97-109-120-125-135,tachycardia associated with QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747799,9/15/2015 16:21:14,1738773586,9/15/2015 16:20:12,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,85,125,,,108,134,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,85-97,125-135,QUINIDINE therapy.,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy.",85 97,125,85,125,108,134,-1,RO-may_prevent,820351,"Temporary overdrive pacing may be the treatment of choice for refractory, recurrent, ventricular tachycardia associated with quinidine therapy",ventricular tachycardia,quinidine
788747800,9/15/2015 17:21:34,1738813899,9/15/2015 17:21:20,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85,THYROID,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:07:46,1738877250,9/15/2015 18:07:28,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85-93-105,THYROID stimulating immunoglobulin;,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:18:10,1738887572,9/15/2015 18:17:57,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85,THYROID,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:22:15,1738890282,9/15/2015 18:21:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85-93-105,THYROID stimulating immunoglobulin;,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:24:29,1738891646,9/15/2015 18:24:16,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85,THYROID,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:25:32,1738892297,9/15/2015 18:25:16,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85-93-105,THYROID stimulating immunoglobulin;,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:26:11,1738892618,9/15/2015 18:25:48,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85-93-105,THYROID stimulating immunoglobulin;,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:28:46,1738893994,9/15/2015 18:27:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85-93-105,THYROID stimulating immunoglobulin;,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:33:54,1738897221,9/15/2015 18:33:34,false,neodev,1.0,33758777,USA,"","",38.95.108.251,146,85,,,160,92,HYPOTHYROIDISM,THYROID,HYPOTHYROIDISM,146,85,THYROID,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747800,9/15/2015 18:35:06,1738898130,9/15/2015 18:34:21,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,146,85,,,160,92,HYPOTHYROIDISM,THYROID,three patients developed HYPOTHYROIDISM in association with,121-127-136-146-161-164-176,64-75-82-85-93-105-121,detectable levels of THYROID stimulating immunoglobulin; three,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies.",146,85,146,85,160,92,-1,RO-may_prevent,820321,"Three patients developed hyperthyroidism, two of whom developed detectable levels of thyroid-stimulating immunoglobulin; three patients developed hypothyroidism in association with high titers of antithyroglobulin and/or antimicrosomal antibodies",hypothyroidism,thyroid
788747801,9/15/2015 16:06:14,1738768121,9/15/2015 16:06:03,false,elite,1.0,31883685,GBR,"","",79.66.244.188,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:07:47,1738768784,9/15/2015 16:07:15,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:13:20,1738770676,9/15/2015 16:12:51,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,diuretics and digoxin CONGESTIVE HEART FAILURE.,100-114-144-155-161-110,88-100-110-114-155-161,"inhibitors, diuretics and DIGOXIN heart failure.","In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:14:24,1738771191,9/15/2015 16:14:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:15:27,1738771567,9/15/2015 16:15:09,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:17:33,1738772256,9/15/2015 16:17:21,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:17:43,1738772319,9/15/2015 16:17:28,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:17:47,1738772335,9/15/2015 16:17:29,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:17:56,1738772401,9/15/2015 16:17:41,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,CONGESTIVE HEART FAILURE.,144-155-161,114,DIGOXIN,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747801,9/15/2015 16:18:24,1738772598,9/15/2015 16:17:35,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,144,114,,,168,121,CONGESTIVE HEART FAILURE,DIGOXIN,"beta blockers ACE inhibitors, diuretics CONGESTIVE HEART FAILURE.",15-84-88-100-144-155-161-20,15-20-84-88-100-110-114-122-125-130-144-155-161,"beta blockers ACE inhibitors, diuretics and DIGOXIN in many patients congestive heart failure.","In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure.",144 155 161,114,144,114,168,121,-1,RO-may_prevent,820158,"In the future, beta-blockers may be the fourth component of the standard regimen of ACE inhibitors, diuretics and digoxin in many patients with congestive heart failure",congestive heart failure,digoxin
788747802,9/15/2015 18:12:23,1738882648,9/15/2015 18:12:10,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128-133,FACTOR VIII concentrate,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:21:58,1738890123,9/15/2015 18:21:44,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128,FACTOR VIII,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:27:52,1738893562,9/15/2015 18:27:39,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128,FACTOR VIII,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:29:10,1738894271,9/15/2015 18:28:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128,FACTOR VIII,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:30:12,1738894943,9/15/2015 18:29:53,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128-133,FACTOR VIII concentrate,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:38:47,1738900261,9/15/2015 18:38:25,false,neodev,1.0,33758777,USA,"","",38.95.108.251,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128,FACTOR VIII,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:40:05,1738901111,9/15/2015 18:39:51,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,112-121-128-133,specific FACTOR VIII concentrate,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:48:57,1738905884,9/15/2015 18:48:41,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,concentrate in multitransfused HAEMOPHILIA A,133-145-148-164-176,121-128-133-145-148,FACTOR VIII concentrate in multitransfused,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 18:49:36,1738906218,9/15/2015 18:48:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128-133,FACTOR VIII concentrate,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747802,9/15/2015 19:03:45,1738913023,9/15/2015 19:03:31,false,zoombucks,1.0,4688131,CAN,BC,Vancouver,216.251.132.22,164,121,,,177,132,HAEMOPHILIA A,FACTOR VIII,HAEMOPHILIA A,164-176,121-128-133,FACTOR VIII concentrate,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients.,164 176,121 128,164,121,177,132,-1,RO-may_treat,820119,This study demonstrates a higher than expected incidence of factor VIII inhibitors associated with the use of a specific factor VIII concentrate in multitransfused haemophilia A patients,haemophilia A,factor VIII
788747803,9/15/2015 18:12:43,1738882979,9/15/2015 18:12:25,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,111,87,,,115,91,PAIN,APAP,PAIN scores,111-116,80-87-92,plasma APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:22:14,1738890278,9/15/2015 18:22:00,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,111,87,,,115,91,PAIN,APAP,PAIN,111,87,APAP,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:28:22,1738893819,9/15/2015 18:27:54,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,111,87,,,115,91,PAIN,APAP,PAIN,111,87,APAP,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:29:27,1738894470,9/15/2015 18:29:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,111,87,,,115,91,PAIN,APAP,PAIN,111,87-92-80,plasma APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:30:37,1738895180,9/15/2015 18:30:13,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,111,87,,,115,91,PAIN,APAP,PAIN scores,111-116,80-87-92,plasma APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:39:10,1738900543,9/15/2015 18:38:49,false,neodev,1.0,33758777,USA,"","",38.95.108.251,111,87,,,115,91,PAIN,APAP,PAIN,111,87,APAP,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:40:22,1738901270,9/15/2015 18:40:06,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,111,87,,,115,91,PAIN,APAP,PAIN chronic pain.,111-186-194,87-92,APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:49:10,1738905971,9/15/2015 18:48:58,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,111,87,,,115,91,PAIN,APAP,APAP concentrations and PAIN scores using a,87-92-107-111-116-123-129,80-87-92-107-111,plasma APAP concentrations and pain,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 18:50:51,1738906932,9/15/2015 18:49:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,111,87,,,115,91,PAIN,APAP,PAIN scores,111-116,80-87-92,plasma APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747803,9/15/2015 19:03:58,1738913157,9/15/2015 19:03:47,false,zoombucks,1.0,4688131,CAN,BC,Vancouver,216.251.132.22,111,87,,,115,91,PAIN,APAP,PAIN,111,80-87-92,plasma APAP concentrations,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain.",111,87,111,87,115,91,-1,RO-may_treat,820142,"Plasma APAP and APAP metabolite concentrations were measured in the volunteers, plasma APAP concentrations and pain scores using a visual analog scale were measured in the patients with chronic pain",pain,APAP
788747804,9/15/2015 15:51:21,1738762097,9/15/2015 15:51:07,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,25,36,,,32,47,NUMBERS,HEPATITIS A,"April 2004, increased NUMBERS of hepatitis A",3-9-15-25-33-36-46,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 15:52:17,1738762441,9/15/2015 15:52:13,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,25,36,,,32,47,NUMBERS,HEPATITIS A,"April 2004, increased NUMBERS of hepatitis A",3-9-15-25-33-36-46,15-25-33-36-46-48-53-59,increased numbers of HEPATITIS A were noted in,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 15:57:03,1738764042,9/15/2015 15:56:15,false,elite,1.0,31883685,GBR,"","",79.66.244.188,25,36,,,32,47,NUMBERS,HEPATITIS A,NUMBERS of hepatitis A,25-33-36-46,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 15:59:12,1738765203,9/15/2015 15:59:05,false,neodev,1,33644825,USA,FL,Fort Lauderdale,65.111.173.161,25,36,,,32,47,NUMBERS,HEPATITIS A,"April 2004, increased NUMBERS of hepatitis A",3-9-15-25-33-36-46,15-25-33-36-46-48-53-59,increased numbers of HEPATITIS A were noted in,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 15:59:34,1738765389,9/15/2015 15:59:06,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,25,36,,,32,47,NUMBERS,HEPATITIS A,NUMBERS,25,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 16:01:45,1738766382,9/15/2015 16:01:29,false,neodev,1,33701549,NLD,"","",85.203.17.207,25,36,,,32,47,NUMBERS,HEPATITIS A,"April 2004, increased NUMBERS of hepatitis A noted",3-9-15-25-33-36-46-53,15-25-33-36-46-48-53-59-79,increased numbers of HEPATITIS A were noted in districts,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 16:02:42,1738766773,9/15/2015 16:02:29,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,25,36,,,32,47,NUMBERS,HEPATITIS A,NUMBERS hepatitis A,25-36-46,36-46-59,HEPATITIS A in,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 16:02:46,1738766802,9/15/2015 16:02:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,25,36,,,32,47,NUMBERS,HEPATITIS A,NUMBERS,25,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 16:03:19,1738767061,9/15/2015 16:02:23,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,25,36,,,32,47,NUMBERS,HEPATITIS A,increased NUMBERS of hepatitis A neighbouring districts in Germany.,15-25-33-36-46-79-89-92-66,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747804,9/15/2015 16:04:38,1738767503,9/15/2015 16:04:29,false,instagc,1,33058612,USA,IL,Glenview,162.229.106.229,25,36,,,32,47,NUMBERS,HEPATITIS A,NUMBERS,25,36-46,HEPATITIS A,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany.",25,36 46,25,36,32,47,-1,RO-may_prevent,820235,"In April 2004, increased numbers of hepatitis A were noted in six neighbouring districts in Germany",numbers,hepatitis A
788747805,9/15/2015 16:24:05,1738774895,9/15/2015 16:23:52,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,100,DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:25:03,1738775222,9/15/2015 16:24:47,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,100,DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:25:10,1738775262,9/15/2015 16:24:52,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE, conduction disturbances and increases in serum digoxin",27-38-44-53-64-77-81-91-94-100,27-38-44-64-77-81-91-94-100-108-113-53,"congestive heart failure, conduction disturbances and increases in serum DIGOXIN were observed.","Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:27:27,1738776069,9/15/2015 16:27:14,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,94-100,serum DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:29:37,1738776860,9/15/2015 16:29:09,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,94-100,serum DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:29:54,1738776935,9/15/2015 16:29:41,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,81-91-94-100-108-113,increases in serum DIGOXIN were observed.,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:34:34,1738778461,9/15/2015 16:33:14,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,94-100,serum DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:34:54,1738778538,9/15/2015 16:34:42,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"were few, but CONGESTIVE HEART FAILURE, conduction disturbances and increases serum observed.",13-18-23-27-38-44-53-64-77-81-113-94,77-81-91-94-100-108-113-5,effects and increases in serum DIGOXIN were observed.,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:35:02,1738778577,9/15/2015 16:34:51,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,94-100,serum DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747805,9/15/2015 16:35:41,1738778757,9/15/2015 16:32:52,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,27,100,,,51,107,CONGESTIVE HEART FAILURE,DIGOXIN,"CONGESTIVE HEART FAILURE,",27-38-44,81-91-94-100,increases in serum DIGOXIN,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.",27 38 44,100,27,100,51,107,-1,RO-may_prevent,820378,"Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed",congestive heart failure,digoxin
788747806,9/15/2015 16:05:45,1738767909,9/15/2015 16:05:28,false,elite,1.0,31883685,GBR,"","",79.66.244.188,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75,LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:06:57,1738768416,9/15/2015 16:06:36,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,58-66-75,warming buffered LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:06:57,1738768417,9/15/2015 16:06:46,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75,LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:12:25,1738770400,9/15/2015 16:11:52,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,102,75,,,106,84,PAIN,LIDOCAINE,reducing the PAIN of,89-98-102-107,58-75-66,warming buffered LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:13:53,1738770958,9/15/2015 16:13:25,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75,LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:14:51,1738771374,9/15/2015 16:14:32,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,66-75,buffered LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:15:03,1738771438,9/15/2015 16:14:48,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75-66,buffered LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:17:13,1738772148,9/15/2015 16:16:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,58-75-66,warming buffered LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:17:20,1738772181,9/15/2015 16:17:04,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75,LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747806,9/15/2015 16:17:38,1738772293,9/15/2015 16:17:12,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,102,75,,,106,84,PAIN,LIDOCAINE,PAIN,102,75,LIDOCAINE,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration.,102,75,102,75,106,84,-1,RO-may_prevent,820344,The purpose of this study was to evaluate the efficacy of warming buffered lidocaine for reducing the pain of infiltration,pain,lidocaine
788747807,9/15/2015 16:25:28,1738775360,9/15/2015 16:25:15,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,122-134,FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:29:41,1738776863,9/15/2015 16:28:57,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA control,191-198,111-122-134,salmeterol FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:34:07,1738778303,9/15/2015 16:33:40,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,122-134,FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:36:16,1738778962,9/15/2015 16:36:03,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,effective in providing ASTHMA control than fluticasone propionate improving,168-178-181-191-198-206-211-223-241,86-94-111-122-134-145-149-163-168-191-211,"inhaled corticosteroids, salmeterol FLUTICASONE PROPIONATE was significantly more effective asthma fluticasone","In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:40:09,1738780693,9/15/2015 16:38:41,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,122-134,FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:40:29,1738780878,9/15/2015 16:39:48,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,94-111-122-134-86,"inhaled corticosteroids, salmeterol FLUTICASONE PROPIONATE","In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:46:07,1738784684,9/15/2015 16:45:46,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,122-134,FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:53:47,1738790667,9/15/2015 16:53:32,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,in ASTHMA fluticasone asthma montelukast monotherapy propionate.,178-191-211-269-379-426-363,66-86-94-111-122-134-145-149-163-75,"agonists (SABAs) inhaled corticosteroids, salmeterol FLUTICASONE PROPIONATE was significantly more","In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 16:54:06,1738790989,9/15/2015 16:53:52,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,ASTHMA,191,122-134,FLUTICASONE PROPIONATE,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747807,9/15/2015 17:09:56,1738806796,9/15/2015 17:09:43,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,191,122,,,197,144,ASTHMA,FLUTICASONE PROPIONATE,more effective in providing ASTHMA control than fluticasone,168-178-181-191-198-206-211-163,86-94-111-122-134-145-149-163-168,"inhaled corticosteroids, salmeterol FLUTICASONE PROPIONATE was significantly more effective","In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate.",191,122 134,191,122,197,144,-1,RO-may_prevent,820297,"In patients previously receiving as-required short-acting beta(2)-agonists (SABAs) or inhaled corticosteroids, salmeterol/fluticasone propionate was significantly more effective in providing asthma control than fluticasone propionate and in improving lung function and asthma symptoms than inhaled corticosteroids (at equivalent or higher dosages), salmeterol or montelukast (as monotherapy or in combination with fluticasone propionate",asthma,fluticasone propionate
788747808,9/15/2015 16:06:54,1738768386,9/15/2015 16:06:33,false,elite,1.0,31883685,GBR,"","",79.66.244.188,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:11:16,1738770034,9/15/2015 16:10:45,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:14:19,1738771163,9/15/2015 16:13:51,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,105,165,,,109,173,PAIN,PROPOFOL,on the PAIN produced injection rocuronium propofol,98-101-105-110-137-150-165,150-161-165-174-177-188-193,"rocuronium and PROPOFOL in comparison with lidocaine,","In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:15:02,1738771443,9/15/2015 16:14:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:16:09,1738771803,9/15/2015 16:15:46,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:18:28,1738772626,9/15/2015 16:18:08,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:18:32,1738772656,9/15/2015 16:18:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:18:40,1738772709,9/15/2015 16:18:24,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:18:54,1738772784,9/15/2015 16:18:24,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,105,165,,,109,173,PAIN,PROPOFOL,"PAIN after intravenous injection rocuronium propofol lidocaine,",105-119-125-137-150-165-193,150-161-165,rocuronium and PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747808,9/15/2015 16:19:45,1738773154,9/15/2015 16:18:59,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,105,165,,,109,173,PAIN,PROPOFOL,PAIN,105,165,PROPOFOL,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups.",105,165,105,165,109,173,-1,RO-may_prevent,820270,"In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups",pain,propofol
788747809,9/15/2015 17:21:54,1738814044,9/15/2015 17:21:36,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:08:16,1738877856,9/15/2015 18:07:48,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:18:24,1738887757,9/15/2015 18:18:11,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:22:41,1738890584,9/15/2015 18:22:16,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:24:45,1738891848,9/15/2015 18:24:30,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:25:47,1738892397,9/15/2015 18:25:33,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:26:28,1738892770,9/15/2015 18:26:12,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:30:05,1738894874,9/15/2015 18:28:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:34:15,1738897501,9/15/2015 18:33:56,false,neodev,1.0,33758777,USA,"","",38.95.108.251,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"HYPERTENSION,",66,83,AMLODIPINE,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747809,9/15/2015 18:36:08,1738898738,9/15/2015 18:35:07,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,66,83,,,78,93,HYPERTENSION,AMLODIPINE,"patients with HYPERTENSION, amlodipine",52-61-66-83,66-83,"hypertension, AMLODIPINE","PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD.",66,83,66,83,78,93,-1,RO-may_treat,820067,"PubMed ID: 15811979  QUESTION  In black or nonblack patients with hypertension, is amlodipine or lisinopril better than chlorthalidone for reducing cardiovascular disease (CVD",hypertension,amlodipine
788747810,9/15/2015 16:08:50,1738769239,9/15/2015 16:08:34,false,elite,1.0,31883685,GBR,"","",79.66.244.188,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD),",48-58-66,118,"(DONEPEZIL,","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:15:28,1738771576,9/15/2015 16:15:05,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD),",48-58-66,118,"(DONEPEZIL,","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:17:51,1738772369,9/15/2015 16:17:13,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, galantamine)",48-58-66-72-77-87-92-107-118-130-147,48-58-92-107-118-130-144-147-66,"Alzheimer disease (AD), cholinesterase inhibitors (DONEPEZIL, rivastigmine, or galantamine)","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:18:24,1738772600,9/15/2015 16:17:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,67,119,,,69,128,AD,DONEPEZIL,Alzheimer disease,48-58,118,"(DONEPEZIL,","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:19:11,1738772851,9/15/2015 16:18:50,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD),",48-58-66,118,"(DONEPEZIL,","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:20:37,1738773380,9/15/2015 16:20:14,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,67,119,,,69,128,AD,DONEPEZIL,"(donepezil, rivastigmine, galantamine)",118-130-147,144-118,"(DONEPEZIL, or","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:20:46,1738773406,9/15/2015 16:20:25,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, galantamine)",48-58-66-72-77-87-92-107-118-130-147,48-58-66-72-77-92-107-118-130-144-147-87,"Alzheimer disease (AD), does treatment with cholinesterase inhibitors (DONEPEZIL, rivastigmine, or galantamine)","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:20:52,1738773416,9/15/2015 16:20:24,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD),",48-58-66,118,"(DONEPEZIL,","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:21:07,1738773516,9/15/2015 16:20:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD),",48-58-66,92-107,cholinesterase inhibitors,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747810,9/15/2015 16:23:08,1738774379,9/15/2015 16:20:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,67,119,,,69,128,AD,DONEPEZIL,"Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",48-58-66-72-77-87-92-107-118-130-144-147-160-168-177,48-58-66-72-77-87-92-107-118-130-144-147-160-168-177,"Alzheimer disease (AD), does treatment with cholinesterase inhibitors (DONEPEZIL, rivastigmine, or galantamine) improve clinical outcomes.","PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes.",,,67,119,69,128,-1,RO-may_treat,820068,"PubMed ID: 16081444  QUESTION  In patients with Alzheimer disease (AD), does treatment with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) improve clinical outcomes",AD,donepezil
788747811,9/15/2015 16:49:56,1738787423,9/15/2015 16:48:02,false,prodege,1.0,6309240,USA,CA,San Diego,205.241.40.254,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 16:52:04,1738789185,9/15/2015 16:51:42,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 16:58:56,1738795663,9/15/2015 16:58:23,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 17:19:36,1738812912,9/15/2015 17:19:21,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:05:49,1738874846,9/15/2015 18:05:36,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:07:44,1738877201,9/15/2015 18:07:34,false,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:16:17,1738886147,9/15/2015 18:16:02,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:17:23,1738887035,9/15/2015 18:17:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:22:15,1738890311,9/15/2015 18:22:01,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,136,FAMCICLOVIR.,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747811,9/15/2015 18:23:47,1738891278,9/15/2015 18:22:36,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,92,136,,,106,147,GENITAL HERPES,FAMCICLOVIR,GENITAL HERPES:,92-100,108-119-136,"acyclovir, valacyclovir FAMCICLOVIR.","Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir.",92 100,136,92,136,106,147,-1,RO-may_prevent,820272,"Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir",genital herpes,famciclovir
788747812,9/15/2015 15:59:40,1738765469,9/15/2015 15:59:21,false,elite,1.0,31883685,GBR,"","",79.66.244.188,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:01:37,1738766351,9/15/2015 16:01:15,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:04:09,1738767337,9/15/2015 16:03:55,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,85,123,,,89,132,PAIN,CAPSAICIN,PAIN,85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:06:11,1738768062,9/15/2015 16:05:52,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,85,123,,,89,132,PAIN,CAPSAICIN,"intraoral PAIN evoked by topical application of capsaicin gingiva,",75-85-90-97-100-108-120-123-140,100-108-120-123-133-136-140,"topical application of CAPSAICIN to the gingiva,","The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:08:05,1738768891,9/15/2015 16:07:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,85-75,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:09:57,1738769609,9/15/2015 16:09:30,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:10:37,1738769775,9/15/2015 16:09:52,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:10:51,1738769939,9/15/2015 16:09:44,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:11:28,1738770108,9/15/2015 16:10:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,85,123,,,89,132,PAIN,CAPSAICIN,intraoral PAIN,75-85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747812,9/15/2015 16:11:58,1738770223,9/15/2015 16:11:44,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,85,123,,,89,132,PAIN,CAPSAICIN,PAIN,85,123,CAPSAICIN,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC.",85,123,85,123,89,132,-1,RO-may_prevent,820328,"The aims of this study were to investigate possible sex differences in (a) intraoral pain evoked by topical application of capsaicin to the gingiva, and (b) the modulation of this pain by diffuse noxious inhibitory controls (DNIC",pain,capsaicin
788747813,9/15/2015 18:11:04,1738881106,9/15/2015 18:10:47,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:20:35,1738889239,9/15/2015 18:20:22,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:27:00,1738893072,9/15/2015 18:26:43,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:27:32,1738893366,9/15/2015 18:27:17,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:28:59,1738894123,9/15/2015 18:28:46,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,24-37,bactericidal RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:29:07,1738894236,9/15/2015 18:28:51,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:37:29,1738899520,9/15/2015 18:37:07,false,neodev,1.0,33758777,USA,"","",38.95.108.251,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:38:56,1738900391,9/15/2015 18:38:40,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,37,RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:44:05,1738903240,9/15/2015 18:42:36,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,TUBERCULOSIS,104,24-37,bactericidal RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747813,9/15/2015 18:44:15,1738903302,9/15/2015 18:43:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,104,37,,,116,47,TUBERCULOSIS,RIFAMPICIN,chemotherapy of TUBERCULOSIS,88-101-104,24-37,bactericidal RIFAMPICIN,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy.",104,37,104,37,116,47,-1,RO-may_prevent,820188,"The introduction of the bactericidal rifampicin led to the latest major landmark in the chemotherapy of tuberculosis in the past 20 years: namely, short-course chemotherapy",tuberculosis,rifampicin
788747814,9/15/2015 16:04:16,1738767408,9/15/2015 16:03:59,false,elite,1.0,31883685,GBR,"","",79.66.244.188,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:04:21,1738767441,9/15/2015 16:04:03,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:05:49,1738767922,9/15/2015 16:05:37,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:09:31,1738769455,9/15/2015 16:09:06,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,dystonia levodopa PARKINSON'S DISEASE,35-107-119-60,35-48-52-57-60-69-72-76-107-119,dystonia the role of LEVODOPA in the development Parkinson's disease,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:11:07,1738769975,9/15/2015 16:10:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:12:35,1738770456,9/15/2015 16:12:17,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:13:45,1738770874,9/15/2015 16:13:32,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:15:43,1738771657,9/15/2015 16:15:27,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:15:57,1738771724,9/15/2015 16:15:37,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,fluctuations in PARKINSON'S DISEASE,91-104-107-119,60-69-72-76-91-107-119,LEVODOPA in the development fluctuations Parkinson's disease,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747814,9/15/2015 16:16:19,1738771854,9/15/2015 16:15:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,107,60,,,126,68,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE,107-119,60,LEVODOPA,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed.,107 119,60,107,60,126,68,-1,RO-may_treat,820126,The role of dopamine deficiency in dystonia and the role of levodopa in the development of fluctuations in Parkinson's disease are discussed,Parkinson's disease,levodopa
788747815,9/15/2015 16:19:25,1738772990,9/15/2015 16:19:11,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108-116,GLUCOSE concentrations.,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:20:53,1738773417,9/15/2015 16:20:38,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108,GLUCOSE,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:21:01,1738773488,9/15/2015 16:20:48,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"precipitate manifestations of HYPOGLYCEMIA, regardless of glucose concentrations.",50-62-77-80-94-105-108-116,62-77-80-94-105-108-116-50,"precipitate manifestations of hypoglycemia, regardless of GLUCOSE concentrations.","Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:21:12,1738773575,9/15/2015 16:20:52,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108,GLUCOSE,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:21:22,1738773631,9/15/2015 16:21:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108-116,GLUCOSE concentrations.,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:21:58,1738773859,9/15/2015 16:21:18,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108,GLUCOSE,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:22:03,1738773893,9/15/2015 16:21:37,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108,GLUCOSE,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:23:43,1738774666,9/15/2015 16:23:28,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"HYPOGLYCEMIA,",80,108-116,GLUCOSE concentrations.,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:23:44,1738774687,9/15/2015 16:23:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"precipitate manifestations of HYPOGLYCEMIA, regardless of glucose concentrations.",50-62-77-80-94-105-108-116,80-94-105-108-116,"hypoglycemia, regardless of GLUCOSE concentrations.","Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747815,9/15/2015 16:27:09,1738775962,9/15/2015 16:26:55,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,80,108,,,92,115,HYPOGLYCEMIA,GLUCOSE,"manifestations of HYPOGLYCEMIA,",62-77-80,94-105-108-116,regardless of GLUCOSE concentrations.,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations.",80,108,80,108,92,115,-1,RO-may_treat,820022,"Rapid changes in serum glucose concentrations may precipitate manifestations of hypoglycemia, regardless of glucose concentrations",hypoglycemia,glucose
788747816,9/15/2015 16:03:58,1738767289,9/15/2015 16:03:46,false,elite,1.0,31883685,GBR,"","",79.66.244.188,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,63,HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:04:02,1738767309,9/15/2015 16:03:46,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,36-48-63,intravenous unfractionated HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:05:36,1738767821,9/15/2015 16:05:25,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,63,HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:09:05,1738769321,9/15/2015 16:08:32,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,Treatment of VENOUS THROMBOSIS heparin,0-10-13-20-63,0-10-13-20-63-130-134-144,Treatment of venous thrombosis HEPARIN low molecular weight,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:10:56,1738769938,9/15/2015 16:10:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,63,HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:12:16,1738770334,9/15/2015 16:12:00,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,48-63,unfractionated HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:13:30,1738770741,9/15/2015 16:13:17,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,63,HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:15:26,1738771553,9/15/2015 16:15:02,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,63,HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:15:36,1738771593,9/15/2015 16:15:18,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS with intravenous unfractionated,13-20-31-36-48,36-48-63-71,intravenous unfractionated HEPARIN administered,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747816,9/15/2015 16:16:24,1738771903,9/15/2015 16:14:30,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,13,63,,,30,70,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,13-20,36-48-63,intravenous unfractionated HEPARIN,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.,13 20,63,13,63,30,70,-1,RO-may_prevent,820208,Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home,venous thrombosis,heparin
788747817,9/15/2015 16:53:15,1738790293,9/15/2015 16:53:01,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 16:56:14,1738793175,9/15/2015 16:56:03,false,prodege,1.0,6309240,USA,CA,San Diego,205.241.40.254,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56-62-70,HBSAG carrier state,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 17:02:25,1738798853,9/15/2015 17:01:14,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56-62-70,HBSAG carrier state,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 17:21:02,1738813639,9/15/2015 17:20:46,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:07:10,1738876490,9/15/2015 18:06:51,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:17:43,1738887249,9/15/2015 18:17:29,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:19:00,1738888200,9/15/2015 18:18:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56-62,HBSAG carrier,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:24:01,1738891415,9/15/2015 18:23:08,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:25:26,1738892268,9/15/2015 18:24:39,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56,HBSAG,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747817,9/15/2015 18:26:14,1738892655,9/15/2015 18:24:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,80,56,,,91,61,HEPATITIS B,HBSAG,HEPATITIS B,80-90,56-62,HBSAG carrier,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection.",80 90,56,80,56,91,61,-1,RO-may_prevent,820200,"These findings indicated that, in a region in which the HBsAg carrier state and hepatitis B are prevalent, routine dental care is not identified as an important factor in the spread of HBV infection",hepatitis B,HBsAg
788747818,9/15/2015 15:59:20,1738765281,9/15/2015 15:59:06,false,elite,1.0,31883685,GBR,"","",79.66.244.188,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:01:14,1738766174,9/15/2015 16:01:00,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:03:53,1738767275,9/15/2015 16:03:40,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:05:50,1738767931,9/15/2015 16:05:19,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,Digitalis patients with CONGESTIVE HEART FAILURE or with cardiac arrhythmias,31-40-45-56-62-70-73-78-86-0,0-45-56-62-78-86,DIGITALIS congestive heart failure cardiac arrhythmias,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:07:43,1738768753,9/15/2015 16:07:23,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:09:29,1738769426,9/15/2015 16:09:12,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:09:40,1738769492,9/15/2015 16:08:32,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:09:51,1738769576,9/15/2015 16:08:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:10:16,1738769709,9/15/2015 16:09:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747818,9/15/2015 16:11:44,1738770195,9/15/2015 16:11:33,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,45,0,,,69,9,CONGESTIVE HEART FAILURE,DIGITALIS,CONGESTIVE HEART FAILURE,45-56-62,0,DIGITALIS,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume.,45 56 62,0,45,0,69,9,-1,RO-may_prevent,820192,Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume,congestive heart failure,Digitalis
788747819,9/15/2015 16:08:00,1738768849,9/15/2015 16:07:42,false,elite,1.0,31883685,GBR,"","",79.66.244.188,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:13:48,1738770912,9/15/2015 16:13:08,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82-86,VITAMIN B12 binders,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:16:08,1738771786,9/15/2015 16:15:29,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"represent VITAMIN B12 DEFICIENCY,",116-126-134-138,12-18-26-30-33-71-74-82-86-94-97,serum vitamin B12 in OC in VITAMIN B12 binders of serum,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:16:56,1738772069,9/15/2015 16:16:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:18:15,1738772538,9/15/2015 16:17:49,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:19:40,1738773096,9/15/2015 16:19:26,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:19:46,1738773155,9/15/2015 16:19:28,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:20:02,1738773202,9/15/2015 16:19:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:20:07,1738773248,9/15/2015 16:19:49,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY, vitamin B12 supplementation",126-134-138-178-186-190,74-82-86-94-97,VITAMIN B12 binders of serum,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747819,9/15/2015 16:20:18,1738773277,9/15/2015 16:19:49,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,126,74,,,148,85,VITAMIN B12 DEFICIENCY,VITAMIN B12,"VITAMIN B12 DEFICIENCY,",126-134-138,74-82,VITAMIN B12,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs.",126 134 138,74 82,126,74,148,85,-1,RO-may_prevent,820215,"The fall of serum vitamin B12 in OC users appears to be due to changes in vitamin B12 binders of serum and does not represent vitamin B12 deficiency, giving no justification for vitamin B12 supplementation in users of OCs",vitamin B12 deficiency,vitamin B12
788747820,9/15/2015 16:32:18,1738777672,9/15/2015 16:32:02,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,168,99,,,175,110,MALARIA,CHLOROQUINE,Plasmodium falciparum MALARIA,146-157-168,84-96-99-111-115-128,combination of CHLOROQUINE and sulphadoxine pyrimethamine,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 16:37:59,1738779736,9/15/2015 16:37:45,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,168,99,,,175,110,MALARIA,CHLOROQUINE,for Plasmodium falciparum MALARIA and for children years pregnant,142-146-157-168-176-180-184-201-211,82-84-96-99-111-115-128-146,a combination of CHLOROQUINE and sulphadoxine pyrimethamine Plasmodium,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 16:43:59,1738783241,9/15/2015 16:43:33,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,168,99,,,175,110,MALARIA,CHLOROQUINE,Plasmodium falciparum MALARIA,146-157-168,99,CHLOROQUINE,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 16:48:28,1738786432,9/15/2015 16:48:01,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,168,99,,,175,110,MALARIA,CHLOROQUINE,Plasmodium falciparum MALARIA,146-157-168,99,CHLOROQUINE,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 16:48:35,1738786516,9/15/2015 16:47:42,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,168,99,,,175,110,MALARIA,CHLOROQUINE,Plasmodium falciparum MALARIA,146-157-168,99,CHLOROQUINE,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 16:56:51,1738793795,9/15/2015 16:56:24,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,168,99,,,175,110,MALARIA,CHLOROQUINE,MALARIA,168,99,CHLOROQUINE,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 17:11:51,1738808639,9/15/2015 17:11:30,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,168,99,,,175,110,MALARIA,CHLOROQUINE,chloroquine and sulphadoxine pyrimethamine for Plasmodium falciparum MALARIA and for children,99-115-128-142-146-157-168-176-180-184-111,82-84-96-99-111-115-128-142-146-157-168,a combination of CHLOROQUINE and sulphadoxine pyrimethamine for Plasmodium falciparum malaria,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 17:15:45,1738811008,9/15/2015 17:15:21,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,168,99,,,175,110,MALARIA,CHLOROQUINE,MALARIA,168,99,CHLOROQUINE,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 17:28:55,1738817659,9/15/2015 17:28:21,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,168,99,,,175,110,MALARIA,CHLOROQUINE,Plasmodium falciparum MALARIA,146-157-168,99-115-128-111,CHLOROQUINE and sulphadoxine pyrimethamine,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747820,9/15/2015 17:40:12,1738831186,9/15/2015 17:40:04,false,prodege,1,1859229,USA,LA,Zachary,72.219.10.101,168,99,,,175,110,MALARIA,CHLOROQUINE,for MALARIA and for children,142-168-176-180-184,82-84-96-99-111,a combination of CHLOROQUINE and,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine.",168,99,168,99,175,110,-1,RO-may_prevent,820318,"The major changes were the introduction of immediate slide microscopy, the use of a combination of chloroquine and sulphadoxine-pyrimethamine for Plasmodium falciparum malaria and for children under 5 years and pregnant women, the discontinuation of single-dose primaquine (previously given as a gametocytocidal agent), and the use of a loading dose of quinine",malaria,chloroquine
788747821,9/15/2015 17:23:23,1738814808,9/15/2015 17:23:07,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95,NON INSULIN,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:10:05,1738880055,9/15/2015 18:09:43,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:19:48,1738888755,9/15/2015 18:19:35,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95,NON INSULIN,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:25:37,1738892336,9/15/2015 18:25:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:26:17,1738892671,9/15/2015 18:26:04,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95,NON INSULIN,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:27:01,1738893096,9/15/2015 18:26:43,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:28:08,1738893690,9/15/2015 18:27:43,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:36:20,1738898902,9/15/2015 18:36:02,false,neodev,1.0,33758777,USA,"","",38.95.108.251,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95,NON INSULIN,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:38:04,1738899876,9/15/2015 18:37:49,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747821,9/15/2015 18:39:47,1738900940,9/15/2015 18:36:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,55,91,,,68,102,HYPERGLYCEMIA,NON-INSULIN,HYPERGLYCEMIA,55,91-95-103-113,NON INSULIN dependent diabetics,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects.,55,91 95,55,91,68,102,-1,RO-may_treat,820104,The effects of bromocriptine treatment on body fat and hyperglycemia were also examined in non-insulin dependent diabetics being treated with oral hypoglycemics (7 subjects) or insulin (7 subjects,hyperglycemia,non-insulin
788747822,9/15/2015 16:03:44,1738767228,9/15/2015 16:03:23,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:03:45,1738767233,9/15/2015 16:03:14,false,elite,1.0,31883685,GBR,"","",79.66.244.188,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:05:24,1738767746,9/15/2015 16:05:06,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:08:31,1738769114,9/15/2015 16:08:11,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,"of AF to ATRIAL FLUTTER with higher ventricular Quinidine, class IA drugs",132-135-138-141-148-156-161-168-186-203-209-212,161-168-180-186-197-203-209,"higher ventricular rate QUINIDINE, other class IA","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:10:38,1738769766,9/15/2015 16:10:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:11:59,1738770233,9/15/2015 16:11:32,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,AF to ATRIAL FLUTTER,135-138-141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:13:17,1738770661,9/15/2015 16:13:03,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,186,"QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:14:28,1738771203,9/15/2015 16:13:38,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,161-168-180-186,"higher ventricular rate QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:15:17,1738771539,9/15/2015 16:14:41,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,AF to ATRIAL FLUTTER with higher ventricular,135-138-141-148-156-161-168,33-45-186-422-433,"Propafenone (IC) QUINIDINE, Ibutilide, dofetilide,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747822,9/15/2015 16:15:21,1738771541,9/15/2015 16:14:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,141,186,,,155,195,ATRIAL FLUTTER,QUINIDINE,ATRIAL FLUTTER,141-148,161-168-180-186,"higher ventricular rate QUINIDINE,","1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart.",141 148,186,141,186,155,195,-1,RO-may_treat,820079,"1.5-3.0 mg/kg over 10-20 minutes Propafenone (IC)  Oral: 600 mg  450-900 mg; reduced dosing with hepatic dysfunction Transformation of AF to atrial flutter with higher ventricular rate  Quinidine, other class IA drugs  Rare with current regimens Transformation of AF to atrial flutter with 1:1 AV conduction and wide QRS complex  Flecainide, propafenone  3.5%-5% Torsade de pointes  Quinidine, other class IA drugs  1%-8% Ibutilide, dofetilide, sotalol  Up to 8% Amiodarone  0.7% VT or VF  Potentially all antiarrhythmic drugs  Rare except when LV dysfunction or congestive heart",atrial flutter,Quinidine
788747823,9/15/2015 17:23:38,1738814926,9/15/2015 17:23:24,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:10:23,1738880377,9/15/2015 18:10:08,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:20:02,1738888927,9/15/2015 18:19:49,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:20:59,1738889496,9/15/2015 18:20:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:26:29,1738892790,9/15/2015 18:26:18,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:28:21,1738893804,9/15/2015 18:28:08,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:28:33,1738893891,9/15/2015 18:27:02,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,18,73,,,22,84,PAIN,BUPIVACAINE,baseline PAIN,9-18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:36:42,1738899068,9/15/2015 18:36:22,false,neodev,1.0,33758777,USA,"","",38.95.108.251,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,73,BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:38:20,1738900044,9/15/2015 18:38:05,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,18,73,,,22,84,PAIN,BUPIVACAINE,PAIN,18,18-73,pain BUPIVACAINE,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747823,9/15/2015 18:43:03,1738902711,9/15/2015 18:41:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,18,73,,,22,84,PAIN,BUPIVACAINE,mean baseline PAIN,4-9-18,73-85,BUPIVACAINE group.,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group.,18,73,18,73,22,84,-1,RO-may_prevent,820373,The mean baseline pain was 2.96 for the lidocaine group and 3.07 for the bupivacaine group,pain,bupivacaine
788747824,9/15/2015 16:07:08,1738768530,9/15/2015 16:06:55,false,elite,1.0,31883685,GBR,"","",79.66.244.188,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:11:37,1738770153,9/15/2015 16:11:17,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:14:49,1738771359,9/15/2015 16:14:21,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,development of TYPE 1 DIABETES.,97-109-112-117-119,22-31-39-42-46-54-60-117-119-112,"dose regimen of NPH insulin used, INSULIN type 1 diabetes.","In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:15:53,1738771685,9/15/2015 16:15:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:16:26,1738771888,9/15/2015 16:16:10,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:18:44,1738772731,9/15/2015 16:18:29,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:18:47,1738772753,9/15/2015 16:18:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:18:55,1738772783,9/15/2015 16:18:41,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,60,INSULIN,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:19:21,1738772972,9/15/2015 16:18:55,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,42-46-54-60-72,"NPH insulin used, INSULIN not","In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747824,9/15/2015 16:19:40,1738773105,9/15/2015 16:19:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,112,60,,,127,67,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,112-117-119,42-46-54-60-68-72-76-82-85-93-97-109-112-119-117,"NPH insulin used, INSULIN did not delay or prevent the development of type 1 diabetes.","In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes.",112 117 119,60,112,60,127,67,-1,RO-may_treat,820116,"In this study, in the dose and regimen of NPH insulin used, insulin did not delay or prevent the development of type 1 diabetes",type 1 diabetes,insulin
788747825,9/15/2015 16:05:07,1738767638,9/15/2015 16:04:53,false,elite,1.0,31883685,GBR,"","",79.66.244.188,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:06:14,1738768120,9/15/2015 16:05:51,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:06:30,1738768209,9/15/2015 16:06:18,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30,GLUCAGON,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:11:24,1738770084,9/15/2015 16:10:57,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,growth hormone glucagon HYPOGLYCEMIA,11-18-69-30,11-18-30-69,growth hormone GLUCAGON hypoglycemia,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:12:29,1738770441,9/15/2015 16:12:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30,GLUCAGON,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:14:11,1738771091,9/15/2015 16:13:56,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:14:32,1738771231,9/15/2015 16:14:18,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:16:40,1738771979,9/15/2015 16:16:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:16:55,1738772056,9/15/2015 16:16:35,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30,GLUCAGON,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747825,9/15/2015 16:18:04,1738772476,9/15/2015 16:16:27,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,69,30,,,81,38,HYPOGLYCEMIA,GLUCAGON,HYPOGLYCEMIA,69,30-39,GLUCAGON deficiencies,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15.,69,30,69,30,81,38,-1,RO-may_treat,820050,Reports of growth-hormone and glucagon deficiencies that manifest as hypoglycemia are less convincing ( 14 ;  15,hypoglycemia,glucagon
788747826,9/15/2015 16:35:17,1738778650,9/15/2015 16:33:30,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78-91,CLOTRIMAZOLE troches,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 16:38:54,1738780114,9/15/2015 16:38:39,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,Milder episodes of ORAL CANDIDIASIS respond to topical therapy,0-7-16-19-24-36-44-47-55,55-63-68-78-91-99-102-107,"therapy with nystatin, CLOTRIMAZOLE troches or oral ketoconazole.","Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 16:45:22,1738784236,9/15/2015 16:45:02,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78-91,CLOTRIMAZOLE troches,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 16:49:20,1738787002,9/15/2015 16:49:04,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78-91,CLOTRIMAZOLE troches,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 16:50:28,1738787769,9/15/2015 16:49:45,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78-91,CLOTRIMAZOLE troches,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 16:57:54,1738794697,9/15/2015 16:57:41,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78,CLOTRIMAZOLE,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 17:12:33,1738809162,9/15/2015 17:12:22,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,"Milder episodes of ORAL CANDIDIASIS respond to topical therapy with nystatin,",0-7-16-19-24-36-44-47-55-63-68,55-63-68-78-91-99-102-107,"therapy with nystatin, CLOTRIMAZOLE troches or oral ketoconazole.","Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 17:16:41,1738811466,9/15/2015 17:16:25,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78,CLOTRIMAZOLE,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 17:29:53,1738818362,9/15/2015 17:29:32,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78,CLOTRIMAZOLE,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747826,9/15/2015 17:43:40,1738837415,9/15/2015 17:43:23,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,19,78,,,35,90,ORAL CANDIDIASIS,CLOTRIMAZOLE,ORAL CANDIDIASIS,19-24,78,CLOTRIMAZOLE,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole.",19 24,78,19,78,35,90,-1,RO-may_prevent,820284,"Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole",oral candidiasis,clotrimazole
788747827,9/15/2015 16:03:14,1738767020,9/15/2015 16:02:50,false,elite,1.0,31883685,GBR,"","",79.66.244.188,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95-97,VITAMIN D and,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:03:22,1738767076,9/15/2015 16:02:59,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:05:05,1738767641,9/15/2015 16:04:53,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:08:11,1738768941,9/15/2015 16:07:35,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,vitamin D prudent OSTEOPOROSIS,87-95-101-148,0-12-19-32-67-72-76-87-95-49,"Maintaining muscle function balance, calcium 1000 mg, sufficient VITAMIN D","Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:10:15,1738769704,9/15/2015 16:09:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:11:31,1738770124,9/15/2015 16:11:11,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:13:03,1738770577,9/15/2015 16:12:48,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:13:35,1738770766,9/15/2015 16:13:01,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:14:26,1738771194,9/15/2015 16:12:49,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,67-72-76-87-95,"1000 mg, sufficient VITAMIN D","Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747827,9/15/2015 16:15:47,1738771679,9/15/2015 16:14:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,148,87,,,160,96,OSTEOPOROSIS,VITAMIN D,OSTEOPOROSIS,148,87-95,VITAMIN D,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention.",148,87 95,148,87,160,96,-1,RO-may_prevent,820222,"Maintaining muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and prudent use of drugs associated with falls and osteoporosis are key components to fracture prevention",osteoporosis,vitamin D
788747828,9/15/2015 16:53:00,1738790068,9/15/2015 16:52:47,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 16:56:02,1738793006,9/15/2015 16:55:50,false,prodege,1.0,6309240,USA,CA,San Diego,205.241.40.254,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 17:01:13,1738797727,9/15/2015 17:00:33,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 17:20:44,1738813468,9/15/2015 17:20:28,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:06:48,1738875995,9/15/2015 18:06:36,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:17:28,1738887083,9/15/2015 18:17:14,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:18:43,1738888016,9/15/2015 18:18:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:23:06,1738890832,9/15/2015 18:22:56,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:24:37,1738891709,9/15/2015 18:24:25,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747828,9/15/2015 18:24:54,1738891987,9/15/2015 18:24:40,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,0,66,,,28,75,LEFT VENTRICULAR HYPERTROPHY,CAPTOPRIL,LEFT VENTRICULAR HYPERTROPHY,0-5-17,66,CAPTOPRIL,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group.,0 5 17,66,0,66,28,75,-1,RO-may_prevent,820163,Left ventricular hypertrophy was present in 13 patients (7 in the captopril and 6 in the doxazosin group,Left ventricular hypertrophy,captopril
788747829,9/15/2015 16:48:01,1738786132,9/15/2015 16:47:15,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",156-148,107-111-118-131,"low normal TESTOSTERONE levels,","LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 16:51:41,1738788856,9/15/2015 16:51:26,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",148-156,107-111-118-131,"low normal TESTOSTERONE levels,","LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 16:58:22,1738795121,9/15/2015 16:57:17,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",148-156,118-131,"TESTOSTERONE levels,","LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 17:19:20,1738812762,9/15/2015 17:19:04,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"HYPOGONADISM,",156,118,TESTOSTERONE,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:05:34,1738874499,9/15/2015 18:05:13,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",148-156,118,TESTOSTERONE,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:07:33,1738876957,9/15/2015 18:07:08,false,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"HYPOGONADISM,",156,118-131,"TESTOSTERONE levels,","LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:16:02,1738885945,9/15/2015 18:15:44,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"HYPOGONADISM,",156,118,TESTOSTERONE,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:17:08,1738886891,9/15/2015 18:15:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",148-156,118,TESTOSTERONE,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:22:35,1738890485,9/15/2015 18:21:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"primary HYPOGONADISM,",148-156,118-131,"TESTOSTERONE levels,","LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747829,9/15/2015 18:23:06,1738890835,9/15/2015 18:21:38,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,156,118,,,168,130,HYPOGONADISM,TESTOSTERONE,"HYPOGONADISM,",156,107-111-118,low normal TESTOSTERONE,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism.",156,118,156,118,168,130,-1,RO-may_treat,820035,"LH and FSH levels also help determine whether hypogonadism is primary or secondary: High levels, even with low-normal testosterone levels, indicate primary hypogonadism, and levels that are low or lower than expected for the testosterone level indicate secondary hypogonadism",hypogonadism,testosterone
788747830,9/15/2015 16:35:36,1738778735,9/15/2015 16:35:18,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF Oral Maximum 40 mg of enalapril maleate,0-5-16-22-30-33-36-39-49,30-33-36-39-49-57,"40 mg of ENALAPRIL MALEATE daily,","277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 16:39:09,1738780208,9/15/2015 16:38:55,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF Oral Maximum 40 enalapril maleate,0-5-16-22-30-49-39,30-33-36-39-49-57-64-70-83-75,"40 mg of ENALAPRIL MALEATE daily, given in divided doses.","277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 16:45:36,1738784435,9/15/2015 16:45:23,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF,0-5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 16:49:40,1738787208,9/15/2015 16:49:21,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,5,39,,,8,56,CHF,ENALAPRIL MALEATE,CHF,5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 16:52:41,1738789709,9/15/2015 16:50:29,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF,0-5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 16:58:08,1738794901,9/15/2015 16:57:56,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,5,39,,,8,56,CHF,ENALAPRIL MALEATE,CHF,5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 17:12:46,1738809341,9/15/2015 17:12:34,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,5,39,,,8,56,CHF,ENALAPRIL MALEATE,"277 CHF Oral Maximum 40 mg of enalapril maleate daily,",0-5-16-22-30-33-36-39-49-57,30-33-36-39-49-57-64-70-73-75-83,"40 mg of ENALAPRIL MALEATE daily, given in 2 divided doses.","277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 17:17:04,1738811702,9/15/2015 17:16:42,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,5,39,,,8,56,CHF,ENALAPRIL MALEATE,CHF,5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 17:30:05,1738818481,9/15/2015 17:29:54,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF,0-5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747830,9/15/2015 17:44:09,1738838343,9/15/2015 17:43:57,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,5,39,,,8,56,CHF,ENALAPRIL MALEATE,277 CHF,0-5,39-49,ENALAPRIL MALEATE,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses.",5,39 49,5,39,8,56,-1,RO-may_treat,820018,"277  CHF  >     Oral  Maximum 40 mg of enalapril maleate daily, given in 2 divided doses",CHF,enalapril maleate
788747831,9/15/2015 16:00:16,1738765739,9/15/2015 16:00:02,false,elite,1.0,31883685,GBR,"","",79.66.244.188,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94-119,antiplatelet ANTIBODY of,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:02:34,1738766739,9/15/2015 16:02:11,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94,antiplatelet ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:04:39,1738767520,9/15/2015 16:04:27,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,94,ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:07:06,1738768502,9/15/2015 16:06:39,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,a IDIOPATHIC THROMBOCYTOPENIC PURPURA.,122-137-148-165,50-59-65-72-77-81-94-137,"platelet count (1,000 mm3) and antiplatelet ANTIBODY idiopathic","Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:09:29,1738769430,9/15/2015 16:08:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,94,ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:10:46,1738769859,9/15/2015 16:10:25,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94,antiplatelet ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:11:50,1738770204,9/15/2015 16:11:20,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94,antiplatelet ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:12:08,1738770260,9/15/2015 16:11:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,94,ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:12:32,1738770455,9/15/2015 16:12:19,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94,antiplatelet ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747831,9/15/2015 16:14:23,1738771190,9/15/2015 16:12:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,137,94,,,172,102,IDIOPATHIC THROMBOCYTOPENIC PURPURA,ANTIBODY,IDIOPATHIC THROMBOCYTOPENIC PURPURA.,137-148-165,81-94,antiplatelet ANTIBODY,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura.",137 148 165,94,137,94,172,102,-1,RO-may_treat,820125,"Further hematological examination proved very low platelet count (1,000/mm3) and antiplatelet antibody in confirmation of a diagnosis of idiopathic thrombocytopenic purpura",idiopathic thrombocytopenic purpura,antibody
788747832,9/15/2015 16:51:33,1738788776,9/15/2015 16:49:57,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,0-19,Analgesics IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 16:52:20,1738789405,9/15/2015 16:52:06,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 16:59:20,1738796007,9/15/2015 16:58:57,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 17:19:53,1738813053,9/15/2015 17:19:37,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:06:02,1738875096,9/15/2015 18:05:50,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:16:34,1738886443,9/15/2015 18:16:22,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:17:57,1738887455,9/15/2015 18:17:24,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:22:30,1738890428,9/15/2015 18:22:16,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:23:55,1738891357,9/15/2015 18:23:08,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747832,9/15/2015 18:24:54,1738891982,9/15/2015 18:23:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,58,19,,,62,28,PAIN,IBUPROFEN,PAIN,58,19,IBUPROFEN,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever.,58,19,58,19,62,28,-1,RO-may_prevent,820252,Analgesics such as ibuprofen and acetaminophen can reduce pain and fever,pain,ibuprofen
788747833,9/15/2015 16:40:07,1738780678,9/15/2015 16:39:56,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,lorazepam interval in volunteers with SCHIZOPHRENIA.,109-118-121-132-137-89,48-56-59-73-85-89-99-121,effects of intramuscular HALOPERIDOL and lorazepam on volunteers,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 16:46:47,1738785194,9/15/2015 16:46:36,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,59-73,intramuscular HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 16:50:51,1738788025,9/15/2015 16:50:38,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,59-73,intramuscular HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 16:55:38,1738792621,9/15/2015 16:55:06,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,59-73,intramuscular HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 17:13:46,1738809933,9/15/2015 17:13:35,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,QT interval in volunteers with SCHIZOPHRENIA.,106-118-121-132-137-109,48-56-59-73-85-89-99-102-106-109,effects of intramuscular HALOPERIDOL and lorazepam on the QT interval,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 17:18:17,1738812203,9/15/2015 17:18:04,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,73,HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 17:31:00,1738819379,9/15/2015 17:30:50,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,59-73-99,intramuscular HALOPERIDOL on,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 18:04:41,1738873406,9/15/2015 18:04:29,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,73,HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 18:06:03,1738875117,9/15/2015 18:05:55,false,clixsense,1,17950689,GBR,L9,Sheffield,146.200.192.103,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,volunteers with SCHIZOPHRENIA.,121-132-137,48-56-59-73-85-89,effects of intramuscular HALOPERIDOL and lorazepam,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747833,9/15/2015 18:06:39,1738875761,9/15/2015 18:06:27,false,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,137,73,,,150,84,SCHIZOPHRENIA,HALOPERIDOL,SCHIZOPHRENIA.,137,59-73,intramuscular HALOPERIDOL,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia.,137,73,137,73,150,84,-1,RO-may_treat,820130,The objective of this study was to estimate the effects of intramuscular haloperidol and lorazepam on the QT interval in volunteers with schizophrenia,schizophrenia,haloperidol
788747834,9/15/2015 18:13:01,1738883312,9/15/2015 18:12:45,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60-68-76,GLUCOSE reagent teststrips,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:22:29,1738890418,9/15/2015 18:22:15,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60,GLUCOSE,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:28:37,1738893912,9/15/2015 18:28:24,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60,GLUCOSE,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:29:48,1738894682,9/15/2015 18:29:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60,GLUCOSE,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:31:00,1738895428,9/15/2015 18:30:40,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60-68-76,GLUCOSE reagent teststrips,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:39:34,1738900831,9/15/2015 18:39:11,false,neodev,1.0,33758777,USA,"","",38.95.108.251,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60,GLUCOSE,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:40:38,1738901440,9/15/2015 18:40:23,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60,GLUCOSE,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:49:25,1738906142,9/15/2015 18:49:12,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,teststrips to detect HYPOGLYCEMIA,76-87-90-97,60-68-76-87,GLUCOSE reagent teststrips to,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 18:52:04,1738907522,9/15/2015 18:50:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60-68-76,GLUCOSE reagent teststrips,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747834,9/15/2015 19:04:30,1738913395,9/15/2015 19:03:51,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,97,60,,,109,67,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,97,60-97,GLUCOSE hypoglycemia,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination.",97,60,97,60,109,67,-1,RO-may_treat,820144,"This prospective, multicenter study examines the ability of glucose reagent teststrips to detect hypoglycemia when used under field conditions compared with simultaneously drawn control samples for laboratory glucose determination",hypoglycemia,glucose
788747835,9/15/2015 16:00:01,1738765675,9/15/2015 15:59:40,false,elite,1.0,31883685,GBR,"","",79.66.244.188,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,", TUBERCULOSIS",3-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:02:10,1738766574,9/15/2015 16:01:39,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,TUBERCULOSIS,16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:04:26,1738767465,9/15/2015 16:04:11,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,TUBERCULOSIS,16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:06:38,1738768273,9/15/2015 16:06:11,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,"63 , 64 XDR TUBERCULOSIS is caused by tuberculosis resistant to rifampin isoniazid",0-3-7-12-16-29-32-39-46-60-70-73-86,46-60-70-73-82-86-159-215-233-247-258,"tuberculosis resistant to RIFAMPIN and isoniazid fluoroquinolone antimycobacterial (capreomycin, kanamycin, amikacin.","63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:08:56,1738769290,9/15/2015 16:08:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,TUBERCULOSIS,16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:10:22,1738769745,9/15/2015 16:09:58,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,XDR TUBERCULOSIS,12-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:11:05,1738769964,9/15/2015 16:10:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,", 64 XDR TUBERCULOSIS",3-7-12-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:11:17,1738770033,9/15/2015 16:10:55,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,XDR TUBERCULOSIS,12-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:12:18,1738770367,9/15/2015 16:11:59,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,", XDR TUBERCULOSIS",3-12-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747835,9/15/2015 16:12:47,1738770512,9/15/2015 16:11:28,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,16,73,,,28,81,TUBERCULOSIS,RIFAMPIN,XDR TUBERCULOSIS,12-16,73,RIFAMPIN,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin.",16,73,16,73,28,81,-1,RO-may_prevent,820209,"63 ,   64   XDR tuberculosis is caused by  M. tuberculosis  resistant to rifampin and isoniazid (multiple-drug resistant strains) that also are resistant to a fluoroquinolone and at least one parenteral second-line antimycobacterial (capreomycin, kanamycin, amikacin",tuberculosis,rifampin
788747836,9/15/2015 16:06:32,1738768226,9/15/2015 16:06:15,false,elite,1.0,31883685,GBR,"","",79.66.244.188,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:10:41,1738769828,9/15/2015 16:07:48,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:13:50,1738770957,9/15/2015 16:13:21,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION and alosetron improves IBS symptoms diarrhea.,114-127-131-141-150-154-177,43-49-58-65-75-84-88-150-154-177,"bowel syndrome (IBS), TEGASEROD improves IBS symptoms IBS symptoms diarrhea.","CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:14:50,1738771358,9/15/2015 16:14:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:15:45,1738771676,9/15/2015 16:15:28,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:18:06,1738772499,9/15/2015 16:17:48,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:18:15,1738772529,9/15/2015 16:17:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:18:57,1738772795,9/15/2015 16:17:34,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:19:07,1738772846,9/15/2015 16:17:59,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65-75-84-88,TEGASEROD improves IBS symptoms,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747836,9/15/2015 16:19:15,1738772877,9/15/2015 16:18:09,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,114,65,,,126,74,CONSTIPATION,TEGASEROD,CONSTIPATION,114,65,TEGASEROD,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea.",114,65,114,65,126,74,-1,RO-may_treat,820070,"CONCLUSION  In patients with the irritable bowel syndrome (IBS), tegaserod improves IBS symptoms in patients with constipation and alosetron improves IBS symptoms in those with diarrhea",constipation,tegaserod
788747837,9/15/2015 17:23:57,1738815097,9/15/2015 17:23:39,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,0-6,6-16,hepatitis B,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:10:46,1738880819,9/15/2015 18:10:25,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen (HBsAg),0-6-16-18-26-34,0-6-16-18-26-34,Serum hepatitis B surface antigen (HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:20:21,1738889121,9/15/2015 18:20:03,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,0-6,34,(HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:26:43,1738892904,9/15/2015 18:26:31,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,0-6,34,(HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:27:15,1738893217,9/15/2015 18:25:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen,0-6-16-18-26,18-26-34,surface antigen (HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:28:45,1738893973,9/15/2015 18:28:34,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B,0-6-16,34,(HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:28:48,1738893996,9/15/2015 18:28:22,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen,0-6-16-18-26,0-6-16-18-26-34,Serum hepatitis B surface antigen (HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:37:04,1738899314,9/15/2015 18:36:43,false,neodev,1.0,33758777,USA,"","",38.95.108.251,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS,0-6,34,(HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:38:39,1738900196,9/15/2015 18:38:21,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B,0-6-16,0-6-16,Serum hepatitis B,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747837,9/15/2015 18:41:33,1738901953,9/15/2015 18:39:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,0,35,,,15,40,SERUM HEPATITIS,HBSAG,SERUM HEPATITIS B surface antigen,0-6-16-18-26,18-26-34,surface antigen (HBSAG),"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed.",0 6,,0,35,15,40,-1,RO-may_prevent,820335,"Serum hepatitis B surface antigen (HBsAg) and antibody titres, HBeAg titre and HBV-DNA concentration were analysed",Serum hepatitis,HBsAg
788747838,9/15/2015 16:07:42,1738768746,9/15/2015 16:07:25,false,elite,1.0,31883685,GBR,"","",79.66.244.188,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,121,"FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:13:06,1738770602,9/15/2015 16:12:01,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE quantity.,139-146,114-121,"plaque FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:15:28,1738771580,9/15/2015 16:15:13,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,139,121,,,145,129,PLAQUE,FLUORIDE,"plaque fluoride, DMFT or PLAQUE quantity.",121-131-136-139-146-114,89-97-110-114-121-131-136-139-146,"topical application) and plaque FLUORIDE, DMFT or plaque quantity.","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:16:42,1738771991,9/15/2015 16:16:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,121,"FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:17:49,1738772337,9/15/2015 16:17:25,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,121,"FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:19:25,1738772994,9/15/2015 16:19:11,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,121,"FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:19:27,1738772998,9/15/2015 16:19:07,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,121,"FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:19:42,1738773136,9/15/2015 16:19:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,114-121,"plaque FLUORIDE,","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:19:47,1738773160,9/15/2015 16:19:35,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,139,121,,,145,129,PLAQUE,FLUORIDE,"plaque fluoride, DMFT or PLAQUE quantity.",121-131-136-139-146-114,114-121-131-136-139,"plaque FLUORIDE, DMFT or plaque","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747838,9/15/2015 16:20:16,1738773272,9/15/2015 16:19:42,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,139,121,,,145,129,PLAQUE,FLUORIDE,PLAQUE,139,110-114-121-131-136-139-146,"and plaque FLUORIDE, DMFT or plaque quantity.","No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity.",139,121,139,121,145,129,-1,RO-may_prevent,820350,"No associations could be demonstrated between fluoride treatment (dentifrice, tablets or topical application) and plaque fluoride, DMFT or plaque quantity",plaque,fluoride
788747839,9/15/2015 16:35:57,1738778846,9/15/2015 16:35:37,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 16:39:25,1738780325,9/15/2015 16:39:10,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,hundred ninety eight TUBERCULOSIS patients with tubercle bacilli resistant to isoniazid,6-14-21-27-40-49-54-63-71-84-81,63-71-81-84-94-98-101-114-119,bacilli resistant to ISONIAZID and or streptomycin were matched,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 16:45:53,1738784564,9/15/2015 16:45:37,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 16:49:57,1738787433,9/15/2015 16:49:41,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 16:53:14,1738790285,9/15/2015 16:52:42,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 16:58:20,1738795088,9/15/2015 16:58:09,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 17:13:02,1738809480,9/15/2015 17:12:47,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,hundred ninety eight TUBERCULOSIS patients with tubercle bacilli resistant to isoniazid,6-14-21-27-40-49-54-63-71-81-84,63-71-81-84-94-98-101-54,tubercle bacilli resistant to ISONIAZID and or streptomycin,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 17:17:21,1738811807,9/15/2015 17:17:05,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 17:30:18,1738818659,9/15/2015 17:30:06,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747839,9/15/2015 17:44:32,1738839182,9/15/2015 17:44:10,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,27,84,,,39,93,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,27,84,ISONIAZID,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli.",27,84,27,84,39,93,-1,RO-may_prevent,820346,"Three hundred ninety-eight tuberculosis patients with tubercle bacilli resistant to isoniazid and/or streptomycin were matched by age, race, sex, and geographic area to an equal number of patients with tubercle bacilli susceptible to 9 drugs, including isoniazid and streptomycin, in an effort to determine whether the risk of infection and disease among contacts of patients with resistant bacilli is different from the risk among contacts to patients with susceptible bacilli",tuberculosis,isoniazid
788747840,9/15/2015 16:04:35,1738767496,9/15/2015 16:04:17,false,elite,1.0,31883685,GBR,"","",79.66.244.188,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS corporis,88-100,111-121-126,PYRETHRIN 0.3% shampoo,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:05:02,1738767623,9/15/2015 16:04:22,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS corporis Pyrethrin,88-100-111,88-100-111,pediculosis corporis PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:06:01,1738767995,9/15/2015 16:05:50,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS,88,111,PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:10:10,1738769698,9/15/2015 16:09:32,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS corporis,88-100,88-100-111-121-126,pediculosis corporis PYRETHRIN 0.3% shampoo,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:12:04,1738770240,9/15/2015 16:11:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS,88,111,PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:13:32,1738770747,9/15/2015 16:12:35,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS corporis Pyrethrin 0.3% shampoo or lotion,88-100-111-121-126-134-137,88-100-111-121-126-134-137,pediculosis corporis PYRETHRIN 0.3% shampoo or lotion,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:14:02,1738771027,9/15/2015 16:13:46,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS,88,111,PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:15:58,1738771725,9/15/2015 16:15:53,false,neodev,1,33011398,USA,VA,Manassas,207.244.82.153,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,"compliance Pediculosis pubis, PEDICULOSIS corporis Pyrethrin 0.3%",58-69-81-88-100-111-121,81-88-100-111-121-126-134,"pubis, pediculosis corporis PYRETHRIN 0.3% shampoo or","advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:16:10,1738771809,9/15/2015 16:15:44,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS,88,111,PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747840,9/15/2015 16:16:23,1738771872,9/15/2015 16:15:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,88,111,,,99,120,PEDICULOSIS,PYRETHRIN,PEDICULOSIS corporis Pyrethrin,88-100-111,88-100-111,pediculosis corporis PYRETHRIN,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure.",88,111,88,111,99,120,-1,RO-may_prevent,820320,"advantage of oral medication is ease of use and increased compliance Pediculosis pubis, pediculosis corporis   Pyrethrin 0.3% shampoo or lotion  Apply shampoo or lotion for 10 min and rinse  First-line therapy  Resistance may occur Lindane lotiona  1 oz applied to affected areas  Second-line therapy  Associated with neurotoxicity; caution is advised in prescribing lindane for patients with conditions that increase risk of seizure",pediculosis,Pyrethrin
788747841,9/15/2015 16:25:02,1738775219,9/15/2015 16:24:50,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35,GLUCOSE,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:28:38,1738776509,9/15/2015 16:28:20,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35-43,GLUCOSE recovery,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:32:57,1738777867,9/15/2015 16:32:21,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35,GLUCOSE,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:35:48,1738778803,9/15/2015 16:35:35,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,glucose recovery from HYPOGLYCEMIA was accompanied by delayed normalization,35-43-52-57-70-74-86-97-89,22-27-32-35-43-52-57-74,rats lack of GLUCOSE recovery from hypoglycemia accompanied,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:37:16,1738779377,9/15/2015 16:36:53,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,recovery from HYPOGLYCEMIA was accompanied by delayed normalization of glucose clearance.,43-52-57-70-74-86-89-97-111-114-122,0-3-22-27-32-35-43,In adrenodemedullated rats lack of GLUCOSE recovery,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:38:03,1738779776,9/15/2015 16:37:23,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35,GLUCOSE,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:39:26,1738780343,9/15/2015 16:38:56,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35-43,GLUCOSE recovery,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:45:28,1738784308,9/15/2015 16:45:06,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35-43-52-57,GLUCOSE recovery from hypoglycemia,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:53:06,1738790151,9/15/2015 16:52:51,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,glucose recovery from HYPOGLYCEMIA was accompanied by delayed glucose clearance.,35-43-52-57-70-74-86-89-114-122,22-27-32-35-57-97-114,rats lack of GLUCOSE hypoglycemia normalization glucose,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747841,9/15/2015 16:53:13,1738790282,9/15/2015 16:53:00,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,57,35,,,69,42,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,57,35,GLUCOSE,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance.,57,35,57,35,69,42,-1,RO-may_treat,820128,In adrenodemedullated rats lack of glucose recovery from hypoglycemia was accompanied by delayed normalization of glucose clearance,hypoglycemia,glucose
788747842,9/15/2015 16:26:17,1738775641,9/15/2015 16:26:02,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION,117-126,72,NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:31:08,1738777281,9/15/2015 16:30:20,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION refractory,117-126-139,65-72,retard NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:36:59,1738779279,9/15/2015 16:36:46,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,nifedipine does improve the treatment of ARTERIAL HYPERTENSION refractory to retard,83-92-100-104-114-117-126-139-150-153-72,46-61-65-72-83-88-92,chlorthalidone and retard NIFEDIPINE does not improve,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:38:24,1738779908,9/15/2015 16:36:25,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION,117-126,65-72,retard NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:42:08,1738781773,9/15/2015 16:41:29,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION refractory,117-126-139,72,NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:45:07,1738784056,9/15/2015 16:42:40,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION refractory,117-126-139,72,NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:47:05,1738785414,9/15/2015 16:46:49,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION,117-126,72,NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:54:40,1738791628,9/15/2015 16:54:20,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,the treatment of ARTERIAL HYPERTENSION refractory to retard nifedipine.,100-104-114-117-126-139-150-153-160,46-61-65-72-83-88-92-160,chlorthalidone and retard NIFEDIPINE does not improve nifedipine.,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 16:54:54,1738791972,9/15/2015 16:54:42,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,ARTERIAL HYPERTENSION,117-126,72,NIFEDIPINE,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747842,9/15/2015 17:10:40,1738807525,9/15/2015 17:10:26,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,117,72,,,138,82,ARTERIAL HYPERTENSION,NIFEDIPINE,improve the treatment of ARTERIAL HYPERTENSION refractory to retard,100-104-114-117-126-139-150-153-92,46-61-65-72-83-88-92-100-104-114-117-126,chlorthalidone and retard NIFEDIPINE does not improve the treatment of Arterial Hypertension,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine.,117 126,72,117,72,138,82,-1,RO-may_treat,820105,These results suggest that the association of chlorthalidone and retard nifedipine does not improve the treatment of Arterial Hypertension refractory to retard nifedipine,Arterial Hypertension,nifedipine
788747843,9/15/2015 18:29:53,1738894751,9/15/2015 18:29:38,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,78,116,,,87,122,PNEUMONIA,OXYGEN,PNEUMONIA,78,116,OXYGEN,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 18:32:26,1738896305,9/15/2015 18:32:10,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,78,116,,,87,122,PNEUMONIA,OXYGEN,Community acquired PNEUMONIA,59-69-78,116-123,OXYGEN Saturation,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 18:41:16,1738901842,9/15/2015 18:41:00,false,neodev,1.0,33758777,USA,"","",38.95.108.251,78,116,,,87,122,PNEUMONIA,OXYGEN,PNEUMONIA,78,116,OXYGEN,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 18:47:00,1738904795,9/15/2015 18:46:31,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,78,116,,,87,122,PNEUMONIA,OXYGEN,Community acquired PNEUMONIA Community Acquired Bacterial Pneumonia community acquired bacterial pneumonia,59-69-78-138-148-157-167-245-255-264-274,116,OXYGEN,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 18:50:28,1738906793,9/15/2015 18:50:21,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,78,116,,,87,122,PNEUMONIA,OXYGEN,Community acquired PNEUMONIA Measure,59-69-78-89,97-102-113-116-123-134-138,#57: Assessment of OXYGEN Saturation for Community,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 19:01:55,1738912275,9/15/2015 18:59:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,78,116,,,87,122,PNEUMONIA,OXYGEN,Community acquired PNEUMONIA Measure,59-69-78-89,116-123,OXYGEN Saturation,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 19:06:13,1738914354,9/15/2015 19:05:33,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,78,116,,,87,122,PNEUMONIA,OXYGEN,Community acquired PNEUMONIA,59-69-78,116-123-134-138-148-157-167,OXYGEN Saturation for Community Acquired Bacterial Pneumonia,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 19:15:08,1738918288,9/15/2015 19:14:40,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,78,116,,,87,122,PNEUMONIA,OXYGEN,PNEUMONIA Measure,78-89,116-123,OXYGEN Saturation,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 19:16:43,1738918953,9/15/2015 19:16:20,false,neodev,1.0,33895262,USA,VA,Mclean,63.141.204.167,78,116,,,87,122,PNEUMONIA,OXYGEN,for Community acquired PNEUMONIA Measure Assessment Oxygen Saturation,55-59-69-78-89-102-116-123,97-102-113-116-123-134-138-245,#57: Assessment of OXYGEN Saturation for Community community,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747843,9/15/2015 19:20:02,1738920676,9/15/2015 19:19:19,false,fusioncash,1.0,20623511,USA,OH,Cleveland,99.126.168.235,78,116,,,87,122,PNEUMONIA,OXYGEN,PNEUMONIA,78,116-123,OXYGEN Saturation,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure.,78,116,78,116,87,122,-1,RO-may_treat,820034,See Table -  History and Physical Examination Elements for Community-acquired Pneumonia  Measure #57: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia  Percentage of patients aged 18 years and older with a diagnosis of community-acquired bacterial pneumonia with oxygen saturation documented and reviewed  What are the administrative criteria needed to implement this measure,Pneumonia,Oxygen
788747844,9/15/2015 16:06:01,1738767996,9/15/2015 16:05:46,false,elite,1.0,31883685,GBR,"","",79.66.244.188,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:07:07,1738768504,9/15/2015 16:06:58,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:07:13,1738768563,9/15/2015 16:06:58,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:12:49,1738770519,9/15/2015 16:12:28,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,Verapamil SUPRAVENTRICULAR TACHYCARDIA in neonates.,58-75-87-90-0,0-90,VERAPAMIL neonates.,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:14:11,1738771083,9/15/2015 16:13:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:15:08,1738771466,9/15/2015 16:14:52,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:15:13,1738771525,9/15/2015 16:15:04,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:17:28,1738772237,9/15/2015 16:17:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:17:28,1738772244,9/15/2015 16:17:15,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,SUPRAVENTRICULAR TACHYCARDIA,58-75,0,VERAPAMIL,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747844,9/15/2015 16:17:34,1738772282,9/15/2015 16:17:18,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,58,0,,,86,9,SUPRAVENTRICULAR TACHYCARDIA,VERAPAMIL,Verapamil SUPRAVENTRICULAR TACHYCARDIA in neonates.,58-75-87-90-0,0-58-75-90,VERAPAMIL supraventricular tachycardia neonates.,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.,58 75,0,58,0,86,9,-1,RO-may_treat,820112,Verapamil should not be used in the initial management of supraventricular tachycardia in neonates,supraventricular tachycardia,Verapamil
788747845,9/15/2015 18:13:32,1738883846,9/15/2015 18:13:18,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:22:54,1738890756,9/15/2015 18:22:44,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:29:05,1738894144,9/15/2015 18:28:53,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:30:24,1738895060,9/15/2015 18:30:11,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:31:30,1738895787,9/15/2015 18:31:17,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:40:14,1738901185,9/15/2015 18:39:59,false,neodev,1.0,33758777,USA,"","",38.95.108.251,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:45:59,1738904181,9/15/2015 18:45:41,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:49:51,1738906346,9/15/2015 18:49:41,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,effective to treat HERPES ZOSTER in these patients.,26-36-39-45-52-59-62-68,0-10-14,ACYCLOVIR was found,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 18:56:16,1738909672,9/15/2015 18:54:43,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747845,9/15/2015 19:04:32,1738913414,9/15/2015 19:04:24,false,zoombucks,1.0,4688131,CAN,BC,Vancouver,216.251.132.22,45,0,,,58,9,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,45-52,0,ACYCLOVIR,Acyclovir was found to be effective to treat herpes zoster in these patients.,45 52,0,45,0,58,9,-1,RO-may_prevent,820283,Acyclovir was found to be effective to treat herpes zoster in these patients,herpes zoster,Acyclovir
788747846,9/15/2015 16:04:52,1738767582,9/15/2015 16:04:36,false,elite,1.0,31883685,GBR,"","",79.66.244.188,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38-44,HBSAG carrier,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:05:49,1738767929,9/15/2015 16:05:03,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,129,38,,,140,43,HEPATITIS B,HBSAG,subclinical HEPATITIS B,117-129-139,38-44-52,HBSAG carrier mother,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:06:17,1738768137,9/15/2015 16:06:02,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38,HBSAG,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:10:55,1738769923,9/15/2015 16:10:16,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38-129-139,HBSAG hepatitis B,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:12:17,1738770337,9/15/2015 16:12:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38,HBSAG,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:13:55,1738770971,9/15/2015 16:13:32,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,129,38,,,140,43,HEPATITIS B,HBSAG,subclinical HEPATITIS B,117-129-139,38-44,HBSAG carrier,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:14:18,1738771129,9/15/2015 16:14:03,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38,HBSAG,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:16:34,1738771947,9/15/2015 16:16:11,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38,HBSAG,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:16:39,1738771983,9/15/2015 16:15:58,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,129,38,,,140,43,HEPATITIS B,HBSAG,subclinical HEPATITIS B,117-129-139,24-32-38-44-52-117-129-139-184-192-199-35,newborn of an HBSAG carrier mother subclinical hepatitis B passive active prophylaxis,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747846,9/15/2015 16:17:11,1738772144,9/15/2015 16:16:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,129,38,,,140,43,HEPATITIS B,HBSAG,HEPATITIS B,129-139,38,HBSAG,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth.",129 139,38,129,38,140,43,-1,RO-may_prevent,820329,"We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth",hepatitis B,HBsAg
788747847,9/15/2015 16:40:24,1738780808,9/15/2015 16:40:09,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,better controlled and HYPOGLYCEMIA and marked hyperglycemia can be minimized.,59-66-77-81-94-98-105-119-126-123,18-26-33-37-45-52-56-66-81-126,"careful follow up, GLUCOSE levels can be controlled hypoglycemia minimized.","Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 16:47:02,1738785373,9/15/2015 16:46:49,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37-45,GLUCOSE levels,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 16:51:07,1738788309,9/15/2015 16:50:52,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37-45,GLUCOSE levels,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 16:56:12,1738793143,9/15/2015 16:55:39,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37-45,GLUCOSE levels,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 17:14:03,1738810062,9/15/2015 17:13:46,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,better controlled and HYPOGLYCEMIA and marked hyperglycemia can be minimized.,59-66-77-81-94-98-105-119-123-126,18-26-33-37-45-52-56-59-66,"careful follow up, GLUCOSE levels can be better controlled","Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 17:18:43,1738812427,9/15/2015 17:18:19,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37,GLUCOSE,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 18:05:00,1738873750,9/15/2015 18:04:43,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37-45,GLUCOSE levels,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 18:06:53,1738876112,9/15/2015 18:06:39,false,instagc,1,13581319,USA,IL,Trenton,208.70.36.12,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37-45,GLUCOSE levels,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 18:15:16,1738885317,9/15/2015 18:14:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37,GLUCOSE,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747847,9/15/2015 18:15:28,1738885520,9/15/2015 18:15:12,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,81,37,,,93,44,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,81,37,GLUCOSE,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized.",81,37,81,37,93,44,-1,RO-may_treat,820075,"Rationale: • With careful follow-up, glucose levels can be better controlled and hypoglycemia and marked hyperglycemia can be minimized",hypoglycemia,glucose
788747848,9/15/2015 16:23:51,1738774741,9/15/2015 16:23:30,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:24:46,1738775130,9/15/2015 16:24:23,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:24:50,1738775147,9/15/2015 16:24:28,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,78,47,,,84,60,ANGINA,NITROGLYCERIN,"nitroglycerin, which abolished ANGINA and improved hemodynamics and electrocardiographic manifestations.",47-62-68-78-85-89-98-111-115-136,47-62-68-78-85-89-98-111-115-136,"NITROGLYCERIN, which abolished angina and improved hemodynamics and electrocardiographic manifestations.","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:27:13,1738775994,9/15/2015 16:27:01,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:29:07,1738776651,9/15/2015 16:28:09,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:29:39,1738776862,9/15/2015 16:28:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,78,47,,,84,60,ANGINA,NITROGLYCERIN,"nitroglycerin, which abolished ANGINA and improved hemodynamics and electrocardiographic manifestations.",47-62-68-78-85-89-98-111-115-136,31-36-44-47-62-68-78,"were reduced by NITROGLYCERIN, which abolished angina","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:32:51,1738777829,9/15/2015 16:32:24,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,78,47,,,84,60,ANGINA,NITROGLYCERIN,"nitroglycerin, abolished ANGINA",47-68-78,23-26-36-44-47,"K+ loss reduced by NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:33:11,1738777986,9/15/2015 16:31:30,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:34:40,1738778485,9/15/2015 16:34:29,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,78,47,,,84,60,ANGINA,NITROGLYCERIN,"nitroglycerin, which abolished ANGINA and improved hemodynamics electrocardiographic manifestations.",47-62-68-78-85-89-98-136-115,31-36-44-47-62-68-78-89-98,"were reduced by NITROGLYCERIN, which abolished angina improved hemodynamics","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747848,9/15/2015 16:34:51,1738778521,9/15/2015 16:34:40,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,78,47,,,84,60,ANGINA,NITROGLYCERIN,ANGINA,78,47,"NITROGLYCERIN,","Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations.",78,47,78,47,84,60,-1,RO-may_prevent,820168,"Lactate production and K+ loss were reduced by nitroglycerin, which abolished angina and improved hemodynamics and electrocardiographic manifestations",angina,nitroglycerin
788747849,9/15/2015 16:08:32,1738769139,9/15/2015 16:08:16,false,elite,1.0,31883685,GBR,"","",79.66.244.188,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:15:03,1738771444,9/15/2015 16:14:18,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:17:12,1738772152,9/15/2015 16:16:31,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,liposomal amphotericin B in patients with FUNGAL INFECTIONS,96-106-119-121-133-138-145-124,22-35-37-43-52-65-67-70-80-96-106-119-145,"amphotericin B lipid complex, AMPHOTERICIN B in colloidal dispersion, liposomal amphotericin B infections","The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:17:56,1738772411,9/15/2015 16:17:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:18:49,1738772761,9/15/2015 16:18:31,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:20:13,1738773265,9/15/2015 16:19:56,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:20:22,1738773298,9/15/2015 16:20:06,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:20:37,1738773378,9/15/2015 16:20:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,amphotericin B in patients with FUNGAL INFECTIONS is also discussed.,106-121-124-133-138-145-156-159-164-119,35-37-43-52-65-67-70-80,"B lipid complex, AMPHOTERICIN B in colloidal dispersion,","The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:20:42,1738773397,9/15/2015 16:20:22,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747849,9/15/2015 16:21:35,1738773660,9/15/2015 16:20:19,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,138,52,,,155,66,FUNGAL INFECTIONS,AMPHOTERICIN B,FUNGAL INFECTIONS,138-145,52-65,AMPHOTERICIN B,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed.",138 145,52 65,138,52,155,66,-1,RO-may_prevent,820330,"The efficacy of using amphotericin B lipid complex, amphotericin B in colloidal dispersion, and liposomal amphotericin B in patients with fungal infections is also discussed",fungal infections,amphotericin B
788747850,9/15/2015 16:51:58,1738789081,9/15/2015 16:51:34,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 16:52:32,1738789596,9/15/2015 16:52:21,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 16:59:57,1738796636,9/15/2015 16:59:21,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 17:20:13,1738813175,9/15/2015 17:19:54,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:06:20,1738875450,9/15/2015 18:06:03,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:16:50,1738886727,9/15/2015 18:16:36,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:18:13,1738887594,9/15/2015 18:17:59,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,arterial or VENOUS THROMBOSIS,92-101-104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:22:42,1738890583,9/15/2015 18:22:31,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:24:08,1738891502,9/15/2015 18:23:56,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747850,9/15/2015 18:24:27,1738891645,9/15/2015 18:24:14,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,104,131,,,121,138,VENOUS THROMBOSIS,HEPARIN,VENOUS THROMBOSIS,104-111,131,HEPARIN.,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin.,104 111,131,104,131,121,138,-1,RO-may_prevent,820332,HIT should be suspected in patients who develop thrombocytopenia with or without associated arterial or venous thrombosis while on heparin,venous thrombosis,heparin
788747851,9/15/2015 18:30:22,1738895053,9/15/2015 18:30:08,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256,ANTITHROMBIN,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 18:42:02,1738902215,9/15/2015 18:41:41,false,neodev,1.0,33758777,USA,"","",38.95.108.251,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256,ANTITHROMBIN,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 18:47:40,1738905218,9/15/2015 18:47:22,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256,ANTITHROMBIN,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:06:49,1738914672,9/15/2015 19:04:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,assay (test for ANTITHROMBIN III DEFICIENCY),162-168-174-178-191-195,233-245-256-269,"chromogenic functional ANTITHROMBIN assay,","Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:07:11,1738914856,9/15/2015 19:06:44,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,245-256-269,"functional ANTITHROMBIN assay,","Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:16:50,1738919008,9/15/2015 19:16:15,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256-269,"ANTITHROMBIN assay,","Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:17:12,1738919169,9/15/2015 19:16:56,false,neodev,1.0,33895262,USA,VA,Mclean,63.141.204.167,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,assay (test for ANTITHROMBIN III DEFICIENCY) Test first with assay.,162-168-174-178-191-195-213-218-224-390,229-233-245-256-269-276-284-111,"chromogenic the chromogenic functional ANTITHROMBIN assay, because this","Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:20:55,1738921103,9/15/2015 19:20:40,false,fusioncash,1.0,20623511,USA,OH,Cleveland,99.126.168.235,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256,ANTITHROMBIN,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:25:25,1738922923,9/15/2015 19:24:30,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,ANTITHROMBIN III DEFICIENCY),178-191-195,256,ANTITHROMBIN,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747851,9/15/2015 19:32:27,1738925093,9/15/2015 19:31:53,false,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,178,256,,,205,268,ANTITHROMBIN III DEFICIENCY,ANTITHROMBIN,(test for ANTITHROMBIN III DEFICIENCY),168-174-178-191-195,229-233-245-256-269,"the chromogenic functional ANTITHROMBIN assay,","Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay.",178 191 195,256,178,256,205,268,-1,RO-may_treat,820098,"Positive values should be confirmed ideally in 6-8 weeks and should be of moderate to high titer Antithrombin: chromogenic functional assay; antithrombin antigen assay (test for antithrombin III deficiency)       Test first with the chromogenic functional antithrombin assay, because this detects both quantitative and qualitative deficiencies; if abnormal, proceed to antithrombin antigen assay",antithrombin III deficiency,antithrombin
788747852,9/15/2015 16:21:38,1738773694,9/15/2015 16:21:23,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:22:09,1738773975,9/15/2015 16:21:52,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:22:13,1738773990,9/15/2015 16:21:52,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,effective in the sheep model of ASTHMA,50-60-67-73-79-82-63,29-40-47-50-60-63-67-73-79-82,NEDOCROMIL SODIUM is effective in the sheep model of asthma,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:22:16,1738774009,9/15/2015 16:22:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:23:39,1738774672,9/15/2015 16:23:09,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:24:32,1738775059,9/15/2015 16:24:13,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:24:45,1738775128,9/15/2015 16:23:48,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,ASTHMA,82,29-40,NEDOCROMIL SODIUM,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:25:25,1738775337,9/15/2015 16:24:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,sheep model of ASTHMA and therefore may be beneficial in the treatment of reversible obstructive airway disease,67-73-79-82-89-93-103-107-110-121-124-128-138-141-152-164-171,6-15-24-29-40-47-50-60-63-67-73-79-82,findings indicate that NEDOCROMIL SODIUM is effective in the sheep model of asthma,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:28:17,1738776399,9/15/2015 16:27:57,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,sheep model of ASTHMA,67-73-79-82,29-40-47-50-60-67-73-79-82,NEDOCROMIL SODIUM is effective in sheep model of asthma,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747852,9/15/2015 16:33:19,1738778025,9/15/2015 16:33:02,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,82,29,,,88,46,ASTHMA,NEDOCROMIL SODIUM,sheep model of ASTHMA and therefore may beneficial,67-73-79-82-89-93-103-110,6-15-24-29-40-47-50-60-82,findings indicate that NEDOCROMIL SODIUM is effective in asthma,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man.,82,29 40,82,29,88,46,-1,RO-may_prevent,820287,These findings indicate that nedocromil sodium is effective in the sheep model of asthma and therefore may be beneficial in the treatment of reversible obstructive airway disease in man,asthma,nedocromil sodium
788747853,9/15/2015 16:22:52,1738774314,9/15/2015 16:22:41,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,32,NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:23:57,1738774828,9/15/2015 16:23:44,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,32,NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:24:10,1738774903,9/15/2015 16:23:53,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,12-29-32-43-46-54,pharmacokinetics of NIMODIPINE in healthy volunteers,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:26:46,1738775799,9/15/2015 16:26:31,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,32,NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:27:26,1738776074,9/15/2015 16:26:52,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,32,NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:28:05,1738776310,9/15/2015 16:27:47,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,12-29-32-43-46-54,pharmacokinetics of NIMODIPINE in healthy volunteers,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:30:35,1738777121,9/15/2015 16:29:53,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,12-29-32,pharmacokinetics of NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:30:51,1738777202,9/15/2015 16:30:37,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,patients with SUBARACHNOID HEMORRHAGE.,72-81-86-99,12-29-32-46-54-43,pharmacokinetics of NIMODIPINE in healthy volunteers,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:34:14,1738778342,9/15/2015 16:34:04,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,SUBARACHNOID HEMORRHAGE.,86-99,32,NIMODIPINE,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747853,9/15/2015 16:34:15,1738778343,9/15/2015 16:34:02,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,86,32,,,109,42,SUBARACHNOID HEMORRHAGE,NIMODIPINE,volunteers in patients with SUBARACHNOID HEMORRHAGE.,69-72-81-86-99-54,9-12-29-32-43-46-54-86-72,on pharmacokinetics of NIMODIPINE in healthy volunteers patients subarachnoid,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.,86 99,32,86,32,109,42,-1,RO-may_treat,820085,Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage,subarachnoid hemorrhage,nimodipine
788747854,9/15/2015 16:23:29,1738774590,9/15/2015 16:23:09,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,103,SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:24:21,1738775005,9/15/2015 16:23:59,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,103,SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:24:27,1738775032,9/15/2015 16:24:11,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,85,103,,,96,107,DEHYDRATION,SALT,"strongly induced by DEHYDRATION, high salt and cold stresses, and abscisic acid treatment.",65-74-82-85-98-103-108-112-117-127-131-140-145,74-82-85-98-103-108-112-117-127-131-140-145-65,"strongly induced by dehydration, high SALT and cold stresses, and abscisic acid treatment.","RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:27:00,1738775887,9/15/2015 16:26:47,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,98-103,high SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:28:08,1738776337,9/15/2015 16:27:27,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,103,SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:28:22,1738776458,9/15/2015 16:28:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,85,103,,,96,107,DEHYDRATION,SALT,"strongly induced by DEHYDRATION, high salt and cold stresses,",65-74-82-85-98-103-108-112-117,82-85-98-103-108-112-117,"by dehydration, high SALT and cold stresses,","RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:31:27,1738777375,9/15/2015 16:30:38,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,98-103,high SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:32:23,1738777686,9/15/2015 16:30:52,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,85,103,,,96,107,DEHYDRATION,SALT,"STZ induced by DEHYDRATION,",57-74-82-85,85-98-103-108-112-117-127-131-140-145,"dehydration, high SALT and cold stresses, and abscisic acid treatment.","RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:34:27,1738778422,9/15/2015 16:34:16,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,85,103,,,96,107,DEHYDRATION,SALT,"strongly induced by DEHYDRATION, high salt and cold stresses,",65-74-82-85-98-103-108-117-112,82-85-98-103-108-112-117-140-145-131,"by dehydration, high SALT and cold stresses, abscisic acid treatment.","RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747854,9/15/2015 16:34:39,1738778472,9/15/2015 16:34:15,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,85,103,,,96,107,DEHYDRATION,SALT,"DEHYDRATION,",85,103-98,high SALT,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment.",85,103,85,103,96,107,-1,RO-may_prevent,820240,"RNA gel-blot analysis showed that expression of AZF2 and STZ was strongly induced by dehydration, high-salt and cold stresses, and abscisic acid treatment",dehydration,salt
788747855,9/15/2015 16:47:14,1738785545,9/15/2015 16:47:03,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 16:51:25,1738788624,9/15/2015 16:51:08,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 16:57:16,1738794146,9/15/2015 16:56:14,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 17:14:11,1738810155,9/15/2015 17:14:03,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,used to treat HERPES ZOSTER or herpes simplex virus infection.,22-27-30-36-43-50-53-60-68-74,0-9-19-22-27-30-36-43,"Finally, ACYCLOVIR is used to treat herpes zoster","Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 17:19:03,1738812624,9/15/2015 17:18:45,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 18:05:12,1738873996,9/15/2015 18:05:00,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 18:07:06,1738876393,9/15/2015 18:06:54,false,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 18:15:31,1738885542,9/15/2015 18:15:17,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 18:15:44,1738885680,9/15/2015 18:15:29,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747855,9/15/2015 18:21:37,1738889931,9/15/2015 18:21:24,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,36,9,,,49,18,HERPES ZOSTER,ACYCLOVIR,HERPES ZOSTER,36-43,9,ACYCLOVIR,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection.",36 43,9,36,9,49,18,-1,RO-may_prevent,820337,"Finally, acyclovir is used to treat herpes zoster or herpes simplex virus infection",herpes zoster,acyclovir
788747856,9/15/2015 15:51:37,1738762164,9/15/2015 15:51:22,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,134,99,,,146,108,CONSTIPATION,LACTULOSE,treatment of chronic CONSTIPATION and fecal impaction.,113-123-126-134-147-151-157,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 15:57:45,1738764358,9/15/2015 15:57:04,false,elite,1.0,31883685,GBR,"","",79.66.244.188,134,99,,,146,108,CONSTIPATION,LACTULOSE,chronic CONSTIPATION,126-134,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 15:59:55,1738765619,9/15/2015 15:59:35,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,134,99,,,146,108,CONSTIPATION,LACTULOSE,chronic CONSTIPATION,126-134,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:01:56,1738766460,9/15/2015 16:01:46,false,neodev,1.0,33701549,NLD,"","",85.203.17.207,134,99,,,146,108,CONSTIPATION,LACTULOSE,QUESTION effectiveness treatment of chronic CONSTIPATION and fecal impaction.,52-113-123-126-134-147-151-157-21,11-31-82-89-95-99-109-113-123-134-157-66,20614462 What of glycol (PEG) and LACTULOSE for treatment of constipation impaction.,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:02:59,1738766923,9/15/2015 16:02:43,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,134,99,,,146,108,CONSTIPATION,LACTULOSE,CONSTIPATION,134,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:03:48,1738767239,9/15/2015 16:03:20,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,134,99,,,146,108,CONSTIPATION,LACTULOSE,treatment of chronic CONSTIPATION and fecal impaction.,113-123-126-134-147-151-157,69-82-89-95-99-109-113-123-126-134,polyethylene glycol (PEG) and LACTULOSE for treatment of chronic constipation,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:03:48,1738767247,9/15/2015 16:02:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,134,99,,,146,108,CONSTIPATION,LACTULOSE,chronic CONSTIPATION,134-126,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:05:25,1738767758,9/15/2015 16:05:16,false,clixsense,1,6338159,CAN,ON,Ottawa,108.168.124.170,134,99,,,146,108,CONSTIPATION,LACTULOSE,treatment of chronic CONSTIPATION and fecal impaction.,113-123-126-134-147-151-157,82-89-95-99-109-113-123,glycol (PEG) and LACTULOSE for treatment of,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:06:20,1738768154,9/15/2015 16:06:08,false,clixsense,1,22751911,NLD,04,Groningen,195.241.153.97,134,99,,,146,108,CONSTIPATION,LACTULOSE,treatment of chronic CONSTIPATION and fecal impaction.,113-123-126-134-147-151-157,82-89-95-99-109-113-123,glycol (PEG) and LACTULOSE for treatment of,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747856,9/15/2015 16:06:45,1738768309,9/15/2015 16:06:15,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,134,99,,,146,108,CONSTIPATION,LACTULOSE,chronic CONSTIPATION,126-134,99,LACTULOSE,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction.,134,99,134,99,146,108,-1,RO-may_treat,820064,PubMed ID: 20614462  QUESTION  What is the relative effectiveness of polyethylene glycol (PEG) and lactulose for treatment of chronic constipation and fecal impaction,constipation,lactulose
788747857,9/15/2015 18:43:41,1738903042,9/15/2015 18:43:23,false,neodev,1.0,33758777,USA,"","",38.95.108.251,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,ASTHMA.,147,59-74,BECLOMETHASONE DIPROPIONATE,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 18:48:36,1738905714,9/15/2015 18:48:24,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,129-140-147,59-74-87,BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:08:54,1738915636,9/15/2015 19:08:35,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,129-140-147,59-74,BECLOMETHASONE DIPROPIONATE,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:19:09,1738920150,9/15/2015 19:18:36,false,neodev,1.0,21515166,NLD,11,Nieuwkoop,83.84.200.25,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,ASTHMA.,147,46-56-59-74-87,schedules of BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:27:12,1738923683,9/15/2015 19:26:56,false,tremorgames,1.0,32655637,CAN,ON,Markham,135.23.223.26,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,140-147-129,59-74-87,BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:30:49,1738924611,9/15/2015 19:30:28,false,bitcoinget,1.0,29516942,USA,CA,Saratoga,107.178.35.226,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,ASTHMA.,147,59-74,BECLOMETHASONE DIPROPIONATE,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:33:11,1738925324,9/15/2015 19:32:28,false,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,129-140-147,59-74-87,BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:39:43,1738927541,9/15/2015 19:39:25,false,prodege,1.0,16101132,GBR,F9,Hayes,2.216.28.167,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,ASTHMA.,147,59-74-87,BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:40:19,1738927747,9/15/2015 19:39:52,false,instagc,1.0,31157999,USA,KS,Topeka,68.102.220.35,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,129-140-147,59-74-87,BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747857,9/15/2015 19:47:08,1738930275,9/15/2015 19:46:47,false,pocketmoneygpt,1.0,34458129,USA,CA,Lake Forest,158.69.137.23,147,59,,,153,86,ASTHMA,BECLOMETHASONE DIPROPIONATE,moderately severe ASTHMA.,129-140-147,39-46-56-59-74-87,dosage schedules of BECLOMETHASONE DIPROPIONATE aerosol,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma.",147,59 74,147,59,153,86,-1,RO-may_prevent,820349,"Laitinen LA, Haahtela T. Effect of two dosage schedules of beclomethasone dipropionate aerosol in the treatment of patients with moderately severe asthma",asthma,beclomethasone dipropionate
788747858,9/15/2015 16:05:27,1738767766,9/15/2015 16:05:08,false,elite,1.0,31883685,GBR,"","",79.66.244.188,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:06:34,1738768242,9/15/2015 16:06:16,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:06:46,1738768308,9/15/2015 16:06:30,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66,FLUORIDE,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:11:50,1738770205,9/15/2015 16:11:25,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,15,66,,,21,74,CARIES,FLUORIDE,CARIES fluoride dentifrice,15-66-75,55-59-63-66-75-86-91-41,toothbrushing and use of FLUORIDE dentifrice were recorded.,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:13:25,1738770715,9/15/2015 16:12:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66,FLUORIDE,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:14:31,1738771233,9/15/2015 16:14:13,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:14:48,1738771338,9/15/2015 16:14:33,false,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:16:55,1738772051,9/15/2015 16:16:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,15,66,,,21,74,CARIES,FLUORIDE,"CARIES data,",15-22,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:17:14,1738772153,9/15/2015 16:16:56,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,15,66,,,21,74,CARIES,FLUORIDE,CARIES,15,66-75,FLUORIDE dentifrice,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747858,9/15/2015 16:17:17,1738772167,9/15/2015 16:16:40,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,15,66,,,21,74,CARIES,FLUORIDE,"CARIES data, frequency toothbrushing fluoride dentifrice",15-22-28-41-66-75,15-41-66-75-22,"caries data, toothbrushing FLUORIDE dentifrice","In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded.",15,66,15,66,21,74,-1,RO-may_prevent,820279,"In addition to caries data, frequency of toothbrushing and use of fluoride dentifrice were recorded",caries,fluoride
788747859,9/15/2015 15:52:14,1738762423,9/15/2015 15:52:06,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,85,55,,,88,64,HAV,HEPATITIS,after exposure to HAV and in international,67-73-82-85-89-93-96,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 15:59:05,1738765124,9/15/2015 15:58:45,false,elite,1.0,31883685,GBR,"","",79.66.244.188,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:00:58,1738766062,9/15/2015 16:00:39,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:03:39,1738767208,9/15/2015 16:03:28,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55,HEPATITIS,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:05:17,1738767731,9/15/2015 16:04:54,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,85,55,,,88,64,HAV,HEPATITIS,hepatitis A after exposure to HAV and in international travelers.,55-65-67-73-82-85-89-93-96-110,41-52-55-65-67-73-82-85,prevention of HEPATITIS A after exposure to HAV,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:07:23,1738768632,9/15/2015 16:07:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:08:25,1738769055,9/15/2015 16:07:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:08:29,1738769107,9/15/2015 16:08:00,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:09:11,1738769337,9/15/2015 16:08:49,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747859,9/15/2015 16:09:19,1738769391,9/15/2015 16:08:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,85,55,,,88,64,HAV,HEPATITIS,HAV,85,55-65,HEPATITIS A,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers.,85,55,85,55,88,64,-1,RO-may_prevent,820203,? See updated ACIP  recommendations  for prevention of hepatitis A after exposure to HAV and in international travelers,HAV,hepatitis
788747860,9/15/2015 16:52:46,1738789823,9/15/2015 16:52:34,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 16:55:49,1738792784,9/15/2015 16:55:39,false,prodege,1.0,6309240,USA,CA,San Diego,205.241.40.254,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 17:00:32,1738797184,9/15/2015 16:59:58,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 17:20:27,1738813319,9/15/2015 17:20:14,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:06:35,1738875716,9/15/2015 18:06:22,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:17:13,1738886936,9/15/2015 18:16:52,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:18:28,1738887823,9/15/2015 18:18:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:22:55,1738890748,9/15/2015 18:22:43,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:24:24,1738891619,9/15/2015 18:24:09,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747860,9/15/2015 18:24:39,1738891761,9/15/2015 18:24:28,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,142,59,,,156,69,DUODENAL ULCER,SUCRALFATE,DUODENAL ULCER.,142-151,59,SUCRALFATE,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer.,142 151,59,142,59,156,69,-1,RO-may_prevent,820285,From these results it is concluded that the association of sucralfate with an H2-antagonist improves the possibility of short-term healing of duodenal ulcer,duodenal ulcer,sucralfate
788747861,9/15/2015 16:53:26,1738790411,9/15/2015 16:53:16,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,230-232-241-249,a positive ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 16:56:32,1738793467,9/15/2015 16:56:15,false,prodege,1.0,6309240,USA,CA,San Diego,205.241.40.254,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,241-249,ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 17:21:20,1738813768,9/15/2015 17:21:03,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,221,241,,,225,248,PAIN,ASPIRIN,PAIN,221,241,ASPIRIN,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:07:27,1738876823,9/15/2015 18:07:10,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,241-249,ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:17:56,1738887425,9/15/2015 18:17:44,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,221,241,,,225,248,PAIN,ASPIRIN,PAIN,221,241,ASPIRIN,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:20:36,1738889238,9/15/2015 18:19:01,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,221,241,,,225,248,PAIN,ASPIRIN,PAIN,221,241,ASPIRIN,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:24:14,1738891555,9/15/2015 18:24:02,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,221,241,,,225,248,PAIN,ASPIRIN,PAIN,221,241,ASPIRIN,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:25:15,1738892171,9/15/2015 18:24:55,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,232-241-249,positive ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:25:47,1738892393,9/15/2015 18:25:28,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,232-241-249,positive ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747861,9/15/2015 18:27:20,1738893267,9/15/2015 18:26:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,221,241,,,225,248,PAIN,ASPIRIN,nocturnal PAIN,211-221,232-241-249,positive ASPIRIN test.,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test.",221,241,221,241,225,248,-1,RO-may_prevent,820179,"Regarding its clinical and radiological appearance, this osteoid osteoma was essentially similar to osteoid osteomas in other locations, i.e., it had an osteolytic nidus surrounded by sclerosis, associated with nocturnal pain and a positive aspirin test",pain,aspirin
788747862,9/15/2015 16:32:42,1738777781,9/15/2015 16:32:19,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 16:38:22,1738779890,9/15/2015 16:38:00,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"dysfunction, a previous THROMBOEMBOLISM, or a hypercoagulable state, indefinitely warfarin",254-267-269-278-295-298-300-316-329-347,300-316-323-329-342-347-356-359-361,"hypercoagulable state, treat indefinitely with WARFARIN to a target","? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 16:44:39,1738783790,9/15/2015 16:44:00,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 16:48:46,1738786600,9/15/2015 16:48:29,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 16:49:14,1738786921,9/15/2015 16:48:36,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 16:57:06,1738793986,9/15/2015 16:56:52,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 17:12:07,1738808876,9/15/2015 17:11:52,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"LV dysfunction, a previous THROMBOEMBOLISM, or a hypercoagulable",254-267-269-278-295-298-300-251,323-329-342-347-356-359-361-368-372-375-379-382,treat indefinitely with WARFARIN to a target INR of 2.5 to 3.5,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 17:16:03,1738811175,9/15/2015 17:15:47,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 17:29:18,1738817933,9/15/2015 17:28:56,false,clixsense,1.0,28352278,GBR,P4,Newbury,81.158.243.105,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747862,9/15/2015 17:43:55,1738837847,9/15/2015 17:43:41,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,278,347,,,293,355,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",278,347,WARFARIN,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and.",278,347,278,347,293,355,-1,RO-may_prevent,820274,"? In patients with a bioprosthetic MV in sinus rhythm, treat with warfarin for the first 3 months after the procedure and aspirin, 80 to 100 mg/d, indefinitely thereafter ? In patients with a mitral bioprosthesis with concomitant atrial fibrillation, LV dysfunction, a previous thromboembolism, or a hypercoagulable state, treat indefinitely with warfarin to a target INR of 2.5 to 3.5 ? In patients with a mechanical mitral prosthesis, treat with warfarin to a target INR of 2.5 to 3.5 and aspirin 80 to 100 mg/d, and",thromboembolism,warfarin
788747863,9/15/2015 15:51:51,1738762277,9/15/2015 15:51:38,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,al. The urokinase PULMONARY EMBOLISM trial: a national,34-38-42-52-62-71-78-80,42-52-62,UROKINASE pulmonary embolism,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 15:58:17,1738764625,9/15/2015 15:57:46,false,elite,1.0,31883685,GBR,"","",79.66.244.188,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,PULMONARY EMBOLISM,52-62,42,UROKINASE,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:00:15,1738765734,9/15/2015 15:59:56,false,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,urokinase PULMONARY EMBOLISM trial:,42-52-62-71,42-52-62-71,UROKINASE pulmonary embolism trial:,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:02:06,1738766543,9/15/2015 16:01:57,false,neodev,1.0,33701549,NLD,"","",85.203.17.207,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,"AA, Cole al. The urokinase PULMONARY EMBOLISM trial: a national",23-34-38-42-52-62-71-78-80-9,31-34-38-42-52-62-71-89-13,Hyers et al. The UROKINASE pulmonary embolism trial: cooperative,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:03:12,1738767013,9/15/2015 16:03:00,false,prodege,1.0,3587109,CAN,NS,Sydney,142.177.43.123,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,PULMONARY EMBOLISM,52-62,42,UROKINASE,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:04:24,1738767460,9/15/2015 16:03:49,false,clixsense,1.0,32053717,GBR,"","",51.174.76.80,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,The urokinase PULMONARY EMBOLISM,38-42-52-62,42-52-62,UROKINASE pulmonary embolism,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:05:20,1738767735,9/15/2015 16:03:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.124.79,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,PULMONARY EMBOLISM,52-62,42,UROKINASE,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:06:26,1738768197,9/15/2015 16:06:23,false,clixsense,1.0,22751911,NLD,04,Groningen,195.241.153.97,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,al. The urokinase PULMONARY EMBOLISM trial: a national,34-38-42-52-62-71-78-80,31-34-38-42-52-62-71,et al. The UROKINASE pulmonary embolism trial:,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:07:14,1738768569,9/15/2015 16:06:48,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,urokinase PULMONARY EMBOLISM trial:,42-52-62-71,38-42-52-62-71,The UROKINASE pulmonary embolism trial:,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747863,9/15/2015 16:08:01,1738768870,9/15/2015 16:07:06,false,fusioncash,1.0,5861591,USA,OK,Muskogee,74.197.206.241,52,42,,,70,51,PULMONARY EMBOLISM,UROKINASE,al. The urokinase PULMONARY EMBOLISM trial: a national,34-38-52-62-71-78-80-42,31-34-38-42-62-71-52,et al. The UROKINASE pulmonary embolism trial:,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study.",52 62,42,52,42,70,51,-1,RO-may_treat,820010,"Sasahara AA, Hyers TM, Cole CM et al. The urokinase pulmonary embolism trial: a national cooperative study",pulmonary embolism,urokinase
788747864,9/15/2015 16:22:40,1738774197,9/15/2015 16:22:27,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES,40,48,ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:23:42,1738774669,9/15/2015 16:23:24,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES,40,48,ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:23:51,1738774763,9/15/2015 16:23:23,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,40,48,,,47,55,ASCITES,ALBUMIN,"labeled albumin, the ASCITES albumin clearance rate, the plasma ascites and ascites plasma albumin filtration rates,",19-27-36-40-48-56-66-72-76-83-91-95-103-110-118-129,36-40-48-56-66-72-76-83-95-103-110-118-129,"the ascites ALBUMIN clearance rate, the plasma ascites ascites plasma albumin filtration rates,","We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:25:54,1738775548,9/15/2015 16:25:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES albumin,40-48,40-48,ascites ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:26:31,1738775722,9/15/2015 16:26:14,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,40,48,,,47,55,ASCITES,ALBUMIN,"ASCITES albumin clearance rate,",40-48-56-66,40-48-56-66,"ascites ALBUMIN clearance rate,","We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:26:51,1738775849,9/15/2015 16:25:50,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES albumin,40-48,48-40,ascites ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:27:45,1738776194,9/15/2015 16:27:08,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,40,48,,,47,55,ASCITES,ALBUMIN,"labeled albumin, the ASCITES albumin clearance rate,",19-27-36-40-48-56-66,27-36-40-48-56-66,"albumin, the ascites ALBUMIN clearance rate,","We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:29:50,1738776905,9/15/2015 16:28:47,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES albumin,40-48,40-48,ascites ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:30:36,1738777133,9/15/2015 16:30:09,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,40,48,,,47,55,ASCITES,ALBUMIN,"ASCITES albumin clearance rate,",40-48-56-66,40-48-56-66,"ascites ALBUMIN clearance rate,","We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747864,9/15/2015 16:34:03,1738778297,9/15/2015 16:33:49,false,instagc,1.0,30398579,USA,MA,Winchendon,73.38.174.116,40,48,,,47,55,ASCITES,ALBUMIN,ASCITES albumin,40-48,40-48,ascites ALBUMIN,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites.",40,48,40,48,47,55,-1,RO-may_treat,820141,"We measured, using labeled albumin, the ascites albumin clearance rate, the plasma-ascites and ascites-plasma albumin filtration rates, the ascites albumin exit rate, and the plasma-ascites and ascites-plasma albumin transfer rates in seven patients with cirrhosis and ascites",ascites,albumin
788747865,9/15/2015 16:21:21,1738773614,9/15/2015 16:21:07,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108,"RANITIDINE,","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:21:50,1738773805,9/15/2015 16:21:30,false,prodege,1.0,27934334,GBR,C8,Croydon,81.159.60.206,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108,"RANITIDINE,","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:21:52,1738773807,9/15/2015 16:21:22,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,four patients with GASTRIC ULCER,7-12-21-26-34,108-120-124-127-131-138-140-152-159-162-168-172,"RANITIDINE, 300 mg day 1, 8 consecutive weeks, or until the ulcer","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:21:59,1738773861,9/15/2015 16:21:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108,"RANITIDINE,","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:22:34,1738774139,9/15/2015 16:22:01,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108,"RANITIDINE,","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:23:07,1738774373,9/15/2015 16:22:38,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108,"RANITIDINE,","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:24:12,1738774940,9/15/2015 16:23:59,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,GASTRIC ULCER,26-34,108-120-124,"RANITIDINE, 300 mg","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:24:48,1738775144,9/15/2015 16:24:03,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,"four patients with GASTRIC ULCER and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine,",7-12-21-26-34-40-44-47-52-61-67-77-80-90-95-103-108,90-95-103-108-120-124-127-130-131-134-138-140-152-159-162-168-172-178-182-188-203,"were treated with RANITIDINE, 300 mg day - 1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:27:56,1738776253,9/15/2015 16:27:42,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,patients with GASTRIC ULCER,12-21-26-34,95-103-108-120-124-127,"treated with RANITIDINE, 300 mg day","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747865,9/15/2015 16:34:01,1738778284,9/15/2015 16:33:47,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,26,108,,,39,118,GASTRIC ULCER,RANITIDINE,four patients with GASTRIC ULCER and 18 with duodenal,7-12-21-26-34-40-44-47-52,90-95-103-108-120-124-127-182,"were treated with RANITIDINE, 300 mg day found","Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed.",26 34,108,26,108,39,118,-1,RO-may_prevent,820231,"Twenty-four patients with gastric ulcer and 18 with duodenal ulcer diagnosed by endoscopy were treated with ranitidine, 300 mg day-1, for 8 consecutive weeks, or until the ulcer was found endoscopically healed",gastric ulcer,ranitidine
788747866,9/15/2015 17:22:47,1738814512,9/15/2015 17:22:29,false,gifthunterclub,1.0,29582088,GBR,I2,Manchester,2.99.153.19,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:09:16,1738879090,9/15/2015 18:09:02,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:19:17,1738888383,9/15/2015 18:19:03,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:25:09,1738892108,9/15/2015 18:23:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES herpes labialis,78-86-96-103,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:25:48,1738892391,9/15/2015 18:25:34,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:26:30,1738892798,9/15/2015 18:26:16,false,instagc,1.0,20312760,GBR,O1,Dukinfield,2.96.59.31,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:27:25,1738893327,9/15/2015 18:27:05,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:35:18,1738898271,9/15/2015 18:34:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:35:23,1738898320,9/15/2015 18:35:02,false,neodev,1.0,33758777,USA,"","",38.95.108.251,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES,78-86,47,VALACYCLOVIR,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747866,9/15/2015 18:37:17,1738899433,9/15/2015 18:36:58,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,78,47,,,92,59,GENITAL HERPES,VALACYCLOVIR,GENITAL HERPES herpes labialis (cold sores.,78-86-96-103-112-118,47-78-86-96-103,VALACYCLOVIR genital herpes herpes labialis,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores.,78 86,47,78,47,92,59,-1,RO-may_treat,820031,1  Advice to Patients  •  Advise patients that valacyclovir is not a cure for genital herpes or herpes labialis (cold sores,genital herpes,valacyclovir
788747867,9/15/2015 16:26:02,1738775575,9/15/2015 16:25:48,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:30:19,1738777028,9/15/2015 16:30:00,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:36:24,1738779050,9/15/2015 16:35:22,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:36:45,1738779202,9/15/2015 16:36:32,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,40,64,,,44,73,PAIN,LIDOCAINE,and buffering on PAIN of infiltration of lidocaine.,23-27-37-40-45-48-61-64,27-40-45-48-61-64-15,warming buffering pain of infiltration of LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:41:28,1738781382,9/15/2015 16:40:59,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,40,64,,,44,73,PAIN,LIDOCAINE,PAIN of infiltration,40-45-48,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:42:39,1738782046,9/15/2015 16:41:15,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:46:47,1738785176,9/15/2015 16:46:33,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:54:18,1738791238,9/15/2015 16:54:02,false,elite,1.0,33798502,USA,VA,Manassas,207.244.77.3,40,64,,,44,73,PAIN,LIDOCAINE,and buffering on PAIN of infiltration of lidocaine.,23-27-37-40-45-48-61-64,45-48-61-64-27,buffering of infiltration of LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 16:54:41,1738791674,9/15/2015 16:54:28,false,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,40,64,,,44,73,PAIN,LIDOCAINE,PAIN,40,64,LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747867,9/15/2015 17:10:25,1738807283,9/15/2015 17:10:10,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,40,64,,,44,73,PAIN,LIDOCAINE,and buffering on PAIN of infiltration of lidocaine.,23-27-37-40-45-48-61-64,45-48-61-64-40,pain of infiltration of LIDOCAINE.,The effects of warming and buffering on pain of infiltration of lidocaine.,40,64,40,64,44,73,-1,RO-may_prevent,820212,The effects of warming and buffering on pain of infiltration of lidocaine,pain,lidocaine
788747868,9/15/2015 18:12:08,1738882386,9/15/2015 18:11:55,false,neodev,1.0,14861092,GBR,V2,Glasgow,90.214.139.127,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:21:43,1738889999,9/15/2015 18:21:28,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:27:38,1738893439,9/15/2015 18:27:28,false,gifthunterclub,1.0,31241093,GBR,Q1,Wallasey,2.217.117.151,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:28:52,1738894033,9/15/2015 18:28:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.179.94,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:29:52,1738894734,9/15/2015 18:29:40,false,clixsense,1.0,19638651,USA,SC,Summerville,174.107.73.211,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:38:24,1738900064,9/15/2015 18:38:09,false,neodev,1.0,33758777,USA,"","",38.95.108.251,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:39:50,1738900961,9/15/2015 18:39:32,false,inboxpounds,1.0,12317706,GBR,J1,Wellingborough,86.164.164.220,54,0,,,61,11,MALARIA,CHLOROQUINE,"MALARIA due to P. vivax, P. ovale or P. malariae.",54-62-66-69-72-79-82-91-94-88,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:48:24,1738905614,9/15/2015 18:47:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,54,0,,,61,11,MALARIA,CHLOROQUINE,"MALARIA due to P. vivax,",54-62-66-69-72,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 18:48:41,1738905748,9/15/2015 18:48:24,false,superrewards,1.0,33199643,USA,WI,La Crosse,138.49.2.136,54,0,,,61,11,MALARIA,CHLOROQUINE,Chloroquine for treatment of MALARIA,0-37-41-51-54,0-12-20-24-54,CHLOROQUINE remains the first malaria,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747868,9/15/2015 19:03:44,1738913012,9/15/2015 19:02:22,false,neodev,1.0,33397209,GBR,X5,Cardiff,81.105.50.218,54,0,,,61,11,MALARIA,CHLOROQUINE,MALARIA,54,0,CHLOROQUINE,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae.",54,0,54,0,61,11,-1,RO-may_prevent,820336,"Chloroquine remains the first choice for treatment of malaria due to P. vivax, P. ovale or P. malariae",malaria,Chloroquine
788747869,9/15/2015 16:24:36,1738775083,9/15/2015 16:24:22,false,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:25:55,1738775547,9/15/2015 16:25:28,false,clixsense,1.0,33115750,GBR,I3,Rochester,90.222.106.192,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,treatment regimen for VIVAX MALARIA,130-138-142-148-120,47-50-55-58-69-72-74-81-120-130-138-142-148,14 days of PRIMAQUINE is a highly effective treatment regimen for vivax malaria,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:28:01,1738776299,9/15/2015 16:27:43,false,instagc,1.0,18960682,GBR,U2,Annan,92.18.213.181,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:31:06,1738777276,9/15/2015 16:30:24,false,elite,1.0,30312592,CAN,ON,Sudbury,66.103.55.12,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:35:21,1738778674,9/15/2015 16:35:08,false,elite,1.0,34356654,USA,DE,"",108.59.11.227,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,well tolerated treatment regimen for VIVAX MALARIA in Thailand.,110-120-130-138-142-148-156-159-105,47-50-55-58-69-72-74-81-91-95,14 days of PRIMAQUINE is a highly effective and generally,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:36:23,1738779047,9/15/2015 16:36:04,false,clixsense,1.0,22947672,GBR,H9,London,146.198.116.72,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,well tolerated treatment regimen for VIVAX MALARIA,105-120-130-138-142-148-110,19-24-29-32-43-47-50-55-58-69-72-74-81,five days of artesunate and 14 days of PRIMAQUINE is a highly effective,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:36:27,1738779083,9/15/2015 16:35:16,false,points4rewards,1.0,20113482,USA,PA,Philadelphia,162.208.49.45,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:36:44,1738779196,9/15/2015 16:36:06,false,clixsense,1.0,33878524,CAN,BC,Princeton,75.156.83.71,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:38:19,1738779849,9/15/2015 16:37:16,false,prodege,1.0,6309240,USA,CA,San Diego,108.178.173.218,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
788747869,9/15/2015 16:44:49,1738783910,9/15/2015 16:44:29,false,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,142,58,,,155,68,VIVAX MALARIA,PRIMAQUINE,VIVAX MALARIA,142-148,58,PRIMAQUINE,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand.,142 148,58,142,58,155,68,-1,RO-may_prevent,820376,The combination of five days of artesunate and 14 days of primaquine is a highly effective and generally well-tolerated treatment regimen for vivax malaria in Thailand,vivax malaria,primaquine
